PubMedHealth treatment related to Allergic Rhinitis: 63
Various medications are available to treat the symptoms:AntihistaminesSteroids (corticosteroids)Chromones (mast cell stabilizers)Leukotriene receptor antagonistsDecongestant nasal drops and spraysThere are also non-drug alternatives such as saline (salt water) nasal sprays and nasal washes (nasal irrigation).Allergen-specific immunotherapy (also known as desensitization) can reduce your sensitivity to allergens over the long term. Like with vaccines, this treatment approach involves being exposed to small amounts of the substance by having it injected or placing it under your tongue. In allergen-specific immunotherapy, you are exposed to the allergen at regular intervals. The treatment takes about three years to complete.
FDA approved drugs:
(show all 19)
| # |
|
Drug Name |
Active Ingredient(s) 18
|
Company |
Approval Date |
| 1 |
|
Allegra
18
|
FEXOFENADINE HYDROCHLORIDE |
Hoechst Marion Roussel |
July 1996 |
Disease/s that Drug Treats:seasonal allergic rhinitis
Indications and Usage:
18
Seasonal Allergic Rhinitis ALLEGRA is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. Symptoms treated effectively were sneezing, rhinorrhea, itchy nose/palate/throat, itchy/watery/red eyes. Chronic Idiopathic Urticaria ALLEGRA is indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. It significantly reduces pruritus and the number of wheals.
DrugBank Targets:
16
Histamine H1 receptor
Mechanism of Action:
18
Target: -
Action: -
FDA: Fexofenadine hydrochloride is an antihistamine with selective peripheral H1-receptor antagonist activity. Both enantiomers of fexofenadine hydrochloride displayed approximately equipotent antihistaminic effects. Fexofenadine inhibited histamine release from peritoneal mast cells in rats. In laboratory animals, no anticholinergic, alpha1-adrenergic or beta-adrenergic-receptor blocking effects were observed. No sedative or other central nervous system effects were observed. Radiolabeled tissue distribution studies in rats indicated that fexofenadine does not cross the blood-brain barrier.
|
| 2 |
|
Allegra-D
18
|
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Hoechst Marion Roussel |
March 1998 |
Disease/s that Drug Treats:nasal congestion due to seasonal allergy
Indications and Usage:
18
DrugBank Targets:
16
16
Histamine H1 receptor|Sodium-dependent noradrenaline transporter|Sodium-dependent dopamine transporter|Alpha-1A adrenergic receptor|Alpha-2A adrenergic receptor|Sodium-dependent serotonin transporter|Beta-2 adrenergic receptor|Beta-1 adrenergic receptor|Nuclear factor of activated T-cells, cytoplasmic 1|Tumor necrosis factor|Nuclear factor kappa-light-chain-enhancer of activated B cells|activator protein 1|Interleukin-2
Mechanism of Action:
18
Target: -
Action: -
FDA: antihistamine|nasal decongestant
|
| 3 |
|
Astelin nasal spray
18
|
AZELASTINE HYDROCHLORIDE |
Wallace Laboratories |
November 1996 |
Disease/s that Drug Treats:seasonal allergic rhinitis
Indications and Usage:
18
Astelin Nasal Spray is an H1-receptor antagonist indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older and for the treatment of the symptoms o
DrugBank Targets:
16
Histamine H1 receptor
Mechanism of Action:
18
Target: -
Action: -
FDA: Azelastine hydrochloride, a phthalazinone derivative, exhibits histamine H1-receptor antagonist activity in isolated tissues, animal models, and humans. Astelin Nasal Spray is administered as a racemic mixture with no difference in pharmacologic activity noted between the enantiomers in in vitro studies. The major metabolite, desmethylazelastine, also possesses H1-receptor antagonist activity.
|
| 4 |
|
Atrovent
18
|
IPRATROPIUM BROMIDE |
Boehringer Ingelheim |
January 1996 |
Disease/s that Drug Treats:runny nose due to allergies and the common cold
Indications and Usage:
18
ATROVENT Nasal Spray 0.03% is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children age 6 years and older. ATROVENT Nasal Spray 0.03% does not relieve nasal congestion, sneezing, or postnasal drip associated with allergic or nonallergic perennial rhinitis. CONTRAINDICATIONS Atrovent® (ipratropium bromide) Nasal Spray 0.03% is contraindicated in patients with a history of hypersensitivity to atropine or its derivatives, or to any of the other ingredients. WARNINGS Immediate hypersensitivity reactions may occur after administration of ipratropium bromide, as demonstrated by rare cases of urticaria, angioedema, rash, bronchospasm, anaphylaxis, and oropharyngeal edema.
DrugBank Targets:
16
Muscarinic acetylcholine receptor M1|Muscarinic acetylcholine receptor M2|Muscarinic acetylcholine receptor M3
Mechanism of Action:
18
Target: effect of acetylcholine
Action: blocker
FDA: Ipratropium bromide is an anticholinergic (parasympatholytic) agent which, based on animal studies, appears to inhibit vagally-mediated reflexes by antagonizing the action of acetylcholine, the transmitter agent released at the neuromuscular junctions in the lung. In humans, ipratropium bromide has antisecretory properties and, when applied locally, inhibits secretions from the serous and seromucous glands lining the nasal mucosa. Ipratropium bromide is a quaternary amine that minimally crosses the nasal and gastrointestinal membranes and the blood-brain barrier, resulting in a reduction of the systemic anticholinergic effects (e.g., neurologic, ophthalmic, cardiovascular, and gastrointestinal effects) that are seen with tertiary anticholinergic amines.
|
| 5 |
|
Clarinex
18
|
DESLORATADINE |
Schering-Plough |
February 2002 |
Disease/s that Drug Treats:Allergic rhinitis; Chronic ideopathic urticaria
Indications and Usage:
18
CLARINEX is an H1-receptor antagonist indicated for: * Seasonal Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 2 years of age and older. (1.1) * Perennial Allergic Rhinitis: relief of nasal and non-nasal symptoms in patients 6 months of age and older. (1.2) * Chronic Idiopathic Urticaria: symptomatic relief of pruritus, reduction in the number of hives, and size of hives in patients 6 months of age and older. (1.3)
DrugBank Targets:
16
Histamine H1 receptor
Mechanism of Action:
18
Target: histamine
Action: long-acting tricyclic antagonist
FDA: Desloratadine is a long-acting tricyclic histamine antagonist with selective H1-receptor histamine antagonist activity. Receptor binding data indicates that at a concentration of 2-3 ng/mL (7 nanomolar), desloratadine shows significant interaction with the human histamine H1-receptor. Desloratadine inhibited histamine release from human mast cells in vitro. Results of a radiolabeled tissue distribution study in rats and a radioligand H1-receptor binding study in guinea pigs showed that desloratadine did not readily cross the blood brain barrier. The clinical significance of this finding is unknown.
|
| 6 |
|
Claritin RediTabs
18
|
LORATADINE |
Schering-Plough |
January 1997 |
Disease/s that Drug Treats:seasonal allergy symptoms
Indications and Usage:
18
DrugBank Targets:
16
Histamine H1 receptor
Mechanism of Action:
18
Target: -
Action: -
FDA: -
|
| 7 |
|
Clemastine fumarate syrup
18
|
CLEMASTINE FUMARATE |
Morton Grove Pharmaceuticals |
March 1998 |
FDA Label: Clemastine fumarate syrup
Disease/s that Drug Treats:allergic rhinitis
Indications and Usage:
18
DrugBank Targets:
16
Histamine H1 receptor
Mechanism of Action:
18
Target: -
Action: -
FDA: -
|
| 8 |
|
Dymista
18
|
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE |
Meda Pharmaceuticals Inc |
May 2012 |
Disease/s that Drug Treats:seasonal allergic rhinitis
Indications and Usage:
18
DYMISTA contains an H1-receptor antagonist and a corticosteroid, and is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 6 years of age and older who require treatment with both azelastine hydrochloride and fluticasone propionate for symptomatic relief. (1.1)
DrugBank Targets:
16
16
Histamine H1 receptor|Glucocorticoid receptor|Progesterone receptor|Cytosolic phospholipase A2|Mineralocorticoid receptor|
Mechanism of Action:
18
Target: histamine H1-receptor
Action: antagonist|anti-inflammatory
FDA: DYMISTA: DYMISTA contains both azelastine hydrochloride and fluticasone propionate; therefore, the mechanisms of actions described below for the individual components apply to DYMISTA. These drugs represent two different classes of medications (histamine H1-receptor antagonist and synthetic corticosteroid). Azelastine hydrochloride: Azelastine hydrochloride, a phthalazinone derivative, exhibits histamine H1-receptor antagonist activity in isolated tissues, animal models, and humans. Azelastine hydrochloride in DYMISTA is administered as a racemic mixture with no difference in pharmacologic activity noted between the enantiomers in in vitro studies. The major metabolite, desmethylazelastine, also possesses H1-receptor antagonist activity. Fluticasone propionate: Fluticasone propionate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. In vitro dose response studies on a cloned human glucocorticoid receptor system involving binding and gene expression afforded 50% responses at 1.25 and 0.17 nM concentrations, respectively. Fluticasone propionate was 3-fold to 5-fold more potent than dexamethasone in these assays. Data from the McKenzie vasoconstrictor assay in man also support its potent glucocorticoid activity. The clinical relevance of these findings is unknown. The precise mechanism through which fluticasone propionate affects allergic rhinitis symptoms is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation.
|
| 9 |
|
Flonase Nasal Spray
18
|
FLUTICASONE PROPIONATE |
GlaxoSmithKline |
November 1997 |
Disease/s that Drug Treats:allergic rhinitis
Indications and Usage:
18
FLONASE Nasal Spray is a corticosteroid indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adult and pediatric patients aged 4 years and older. (1)
DrugBank Targets:
16
Glucocorticoid receptor|Progesterone receptor|Cytosolic phospholipase A2|Mineralocorticoid receptor
Mechanism of Action:
18
Target: -
Action: -
FDA: Fluticasone propionate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. Fluticasone propionate has been shown in vitro to exhibit a binding affinity for the human glucocorticoid receptor that is 18 times that of dexamethasone, almost twice that of beclomethasone-17-monopropionate (BMP), the active metabolite of beclomethasone dipropionate, and over 3 times that of budesonide. Data from the McKenzie vasoconstrictor assay in man are consistent with these results. The clinical significance of these findings is unknown. The precise mechanism through which fluticasone propionate affects rhinitis symptoms is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, cytokines) involved in inflammation. In 7 trials in adults, FLONASE Nasal Spray has decreased nasal mucosal eosinophils in 66% of patients (35% for placebo) and basophils in 39% of patients (28% for placebo). The direct relationship of these findings to long-term symptom relief is not known.
|
| 10 |
|
Grastek
18
|
Timothy Grass Pollen Allergen Extract |
Merck |
April 2014 |
Disease/s that Drug Treats:grass pollen-induced allergic rhinitis
Indications and Usage:
18
GRASTEK is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for Timothy grass or cross-reactive grass pollens. GRASTEK is approved for use in persons 5 through 65 years of age. (1)
DrugBank Targets:
-
Mechanism of Action:
18
Target: -
Action: -
FDA: The precise mechanisms of action of allergen immunotherapy are not known.
|
| 11 |
|
Nasacort AQ Nasal Spray
18
|
TRIAMCINOLONE ACETONIDE |
Phone-Poulenc Rorer |
October 1997 |
Disease/s that Drug Treats:allergic rhinitis
Indications and Usage:
18
DrugBank Targets:
16
Glucocorticoid receptor
Mechanism of Action:
18
Target: -
Action: -
FDA: -
|
| 12 |
|
Oralair
18
|
|
Greer Labs |
April 2014 |
Disease/s that Drug Treats:grass pollen-induced allergic rhinitis with or without conjunctivitis
Indications and Usage:
18
DrugBank Targets:
-
Mechanism of Action:
18
Target: -
Action: -
FDA: -
|
| 13 |
|
Patanase
18
|
OLOPATADINE HYDROCHLORIDE |
Alcon |
April 2008 |
Disease/s that Drug Treats:seasonal allergic rhinitis
Indications and Usage:
18
PATANASE Nasal Spray is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older. (1)
DrugBank Targets:
16
Histamine H1 receptor|Protein S100-A1|Protein S100-A12|Protein S100-B|Protein S100-A13|Protein S100-A2
Mechanism of Action:
18
Target: H1 -receptor
Action: selective antagonist
FDA: Olopatadine is a histamine H1 -receptor antagonist. The antihistaminic activity of olopatadine has been documented in isolated tissues, animal models, and humans.
|
| 14 |
|
Qnasl
18
|
BECLOMETHASONE DIPROPIONATE |
Teva Pharmaceutical |
March 2012 |
Disease/s that Drug Treats:seasonal and perennial allergic rhinitis
Indications and Usage:
18
QNASL Nasal Aerosol is a corticosteroid indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older. (1.1)
DrugBank Targets:
16
Glucocorticoid receptor
Mechanism of Action:
18
Target: -
Action: anti-inflammatory
FDA: Beclomethasone dipropionate is a prodrug that is extensively converted to the active metabolite, beclomethasone-17-monopropionate. The precise mechanism through which beclomethasone dipropionate affects rhinitis symptoms is unknown. Corticosteroids have been shown to have multiple anti-inflammatory effects, inhibiting both inflammatory cells (e.g., mast cells, eosinophils, basophils, lymphocytes, macrophages, and neutrophils) and the release of inflammatory mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines). Beclomethasone-17-monopropionate has been shown in vitro to exhibit a binding affinity for the human glucocorticoid receptor which is approximately 13 times that of dexamethasone, 6 times that of triamcinolone acetonide, 1.5 times that of budesonide and 25 times that of beclomethasone dipropionate. The clinical significance of these findings is unknown.
|
| 15 |
|
Ragwitek
18
|
|
Merck |
April 2014 |
Disease/s that Drug Treats:short ragweed pollen-induced allergic rhinitis
Indications and Usage:
18
RAGWITEK is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen. RAGWITEK is approved for use in adults 18 through 65 years of age. (1)
DrugBank Targets:
-
Mechanism of Action:
18
Target: -
Action: -
FDA: The precise mechanisms of action of allergen immunotherapy are not known.
|
| 16 |
|
Rhinocort Aqua Nasal Spray
18
|
BUDESONIDE |
AstraZeneca |
October 1999 |
Disease/s that Drug Treats:Management of nasal symptoms of seasonal or perennial allergic rhinitis in adults and children six years of age or older
Indications and Usage:
18
DrugBank Targets:
16
Glucocorticoid receptor
Mechanism of Action:
18
Target: -
Action: -
FDA: -
|
| 17 |
|
Tri-Nasal Spray
18
|
|
Muro Pharmaceutical |
February 2000 |
Disease/s that Drug Treats:Allergic rhinitis
Indications and Usage:
18
DrugBank Targets:
16
Glucocorticoid receptor
Mechanism of Action:
18
Target: -
Action: -
FDA: -
|
| 18 |
|
Xyzal
18
|
LEVOCETIRIZINE DIHYDROCHLORIDE |
UCB |
May 2007 |
Disease/s that Drug Treats:seasonal and perennial allergic rhinitis and urticaria
Indications and Usage:
18
XYZAL is a histamine H1-receptor antagonist indicated for: * The relief of symptoms associated with seasonal and perennial allergic rhinitis (1.1, 1.2) * The treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria (1.3)
DrugBank Targets:
16
Histamine H1 receptor
Mechanism of Action:
18
Target: H1-receptor
Action: selective antagonist
FDA: Levocetirizine, the active enantiomer of cetirizine, is an antihistamine; its principal effects are mediated via selective inhibition of H1 receptors. The antihistaminic activity of levocetirizine has been documented in a variety of animal and human models. In vitro binding studies revealed that levocetirizine has an affinity for the human H1-receptor 2-fold higher than that of cetirizine (Ki = 3 nmol/L vs. 6 nmol/L, respectively). The clinical relevance of this finding is unknown.
|
| 19 |
|
Zyrtec
18
|
CETIRIZINE HYDROCHLORIDE |
Pfizer |
December 1995 |
Disease/s that Drug Treats:allergy
Indications and Usage:
18
ZYRTEC-D 12 HOUR Extended Release Tablets should be administered when both the antihistaminic properties of cetirizine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired. ZYRTEC-D 12 HOUR Extended Release Tablets are indicated for the relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis in adults and children 12 years of age and older.
DrugBank Targets:
16
Histamine H1 receptor
Mechanism of Action:
18
Target: -
Action: -
FDA: Cetirizine, a human metabolite of hydroxyzine, is an antihistamine; its principal effects are mediated via selective inhibition of peripheral H1 receptors. The antihistaminic activity of cetirizine has been clearly documented in a variety of animal and human models. In vivo and ex vivo animal models have shown negligible anticholinergic and antiserotonergic activity. In clinical studies, however, dry mouth was more common with cetirizine than with placebo. In vitro receptor binding studies have shown no measurable affinity for other than H1 receptors. Autoradiographic studies with radiolabeled cetirizine in the rat have shown negligible penetration into the brain. Ex vivo experiments in the mouse have shown that systemically administered cetirizine does not significantly occupy cerebral H1 receptors.
|
Drugs for Allergic Rhinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 325)
| # |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
| 1 |
|
Histamine |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
75614-87-8, 51-45-6 |
774
|
|
Synonyms:
.beta.-Imidazolyl-4-ethylamine
[3H]histamine
1avn
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1qft
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-imidazolyl)ethylamine
2-(4-Imidazolyl)ethylamine
2-[4-Imidazolyl]ethylamine
2-Imidazol-4-ylethylamine
2-Imidazol-4-yl-ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-imidazoleethylamine
4-Imidazoleethylamine
51-45-6
53290_FLUKA
5-imidazoleethylamine
5-Imidazoleethylamine
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
beta-aminoethylglyoxaline
beta-Aminoethylglyoxaline
beta-aminoethylimidazole
beta-Aminoethylimidazole
beta-aminothethylglyoxaline
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
b-Imidazolyl-4-ethylamine
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
bmse000744
BSPBio_001117
BSPBio_002124
C00388
CCRIS 6535
Ceplene
CHEBI:18295
CHEMBL90
CID774
D08040
Dihydrochloride, histamine
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
histamine
Histamine (DCF)
|
Histamine [USAN]
Histamine Base
Histamine dihydrochloride
Histamine hydrochloride
Histamine, Free Base
Histaminum
Histaminum (TN)
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Hydrochloride, histamine
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L000292
L-Histamin base
L-histamine
L-Histamine
Lopac0_000595
Lopac-H-7250
LS-75835
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
nchembio.87-comp54
nchembio714-comp1
NINDS_000308
NSC 33792
NSC33792
Peremin
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
Spectrum_000845
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
ST073926
STK346752
STOCK5S-55669
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
|
|
| 2 |
|
Capsaicin |
Approved |
Phase 4 |
|
404-86-4 |
1548943
|
|
Synonyms:
(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide
(e)8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide
(E)-8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide(8CL)
(E)-Capsaicin
(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
[(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
12084_FLUKA
21748_FLUKA
21748_SIGMA
21750_FLUKA
21750_SIGMA
360376_ALDRICH
360376_SIGMA
404-86-4
6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl
6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI)
8 Methyl N vanillyl 6 nonenamide
8 Methyl N Vanillyl 6 Nonenamide
8-Methyl-N-vanillyl-6-nonenamide
8-Methyl-N-Vanillyl-6-Nonenamide
8-Methyl-N-vanillyl-trans-6-nonenamide
912457-62-6
AC1LU7K3
AC1Q46B3
Alacan brand OF capsaicin
Alacan Brand of Capsaicin
Antiphlogistine rub a-535 capsaicin
Antiphlogistine Rub A-535 Capsaicin
Axsain
Bio-0615
BPBio1_001053
BRD-K37056290-001-01-1
BRD-K50590187-001-06-6
BRN 2816484
BSPBio_000957
BSPBio_001548
BSPBio_002917
C06866
C-1700
C18H27NO3
Capsaicin
CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN))
Capsaicin (in oleoresin of capsicum)
Capsaicin (JAN/USP)
Capsaicin (Natural)
Capsaicin [in oleoresin of capsicum]
Capsaicin [USAN]
Capsaicin Patch
Capsaicine
CAPSAICINE
Capsicum farmaya
Capsicum Farmaya
Capsidol
Capsin
Capzasin
Carter horner brand OF capsaicin
Carter Horner Brand of Capsaicin
Caswell No. 158
CCRIS 1588
Centrum brand OF capsaicin
Centrum Brand of Capsaicin
CHEBI:3374
CHEMBL294199
CID1548943
D002211
D00250
depletes Substance P
e-Capsaicin
E-CAPSAICIN
EINECS 206-969-8
Elan brand OF capsaicin
Elan Brand of Capsaicin
EPA Pesticide Chemical Code 070701
epsilon-Capsaicin
FEMA No. 3404
Flemming brand OF capsaicin
Flemming Brand of Capsaicin
FT-0082538
Gelcen
HMS1361N10
|
HMS1570P19
HMS1791N10
HMS1921H11
HMS1989N10
HMS2089N11
HMS2092D21
HMS501B16
HSDB 954
I01-2469
IDI1_000354
IDI1_034018
Isodecenoate
Isodecenoate vanillylamide
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
Link brand OF capsaicin
Link Brand of Capsaicin
LS-2138
M1149
M2028_SIGMA
Medicis brand OF capsaicin
Medicis Brand of Capsaicin
MEGxp0_001448
MLS002154049
MolPort-001-742-263
MR3H3
n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide
N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
N-[(4-hydroxy-3-methoxy-phenyl)methyl]nonanamide
NCGC00090853-01
NCGC00090853-02
NCGC00090853-03
NCGC00090853-04
NCGC00090853-06
NCGC00090853-07
NCGC00090853-08
NCGC00090853-09
nchembio.146-comp1
nchembio862-comp2
NCI-C56564
neurotoxic
NGX 4010
NGX-1998
NGX-3781
NGX4010
NGX-4010
NGX-7325
NSC 56353
NSC56353
Prestwick_204
Prestwick2_000879
Prestwick3_000879
Qutenza
S1990_Selleck
SDCCGMLS-0066678.P001
Smaller brand OF capsaicin
Smaller Brand of Capsaicin
SMP2_000337
SMR000718774
SPECTRUM1501128
Spectrum5_000538
Styptysat
Thompson brand OF capsaicin
Thompson Brand of Capsaicin
TL8002946
TQ-1018
trans-8-Methyl-N-vanillyl-6-nonenamide
Transacin
trans-Capsaicin
UNII-S07O44R1ZM
UPCMLD-DP092
UPCMLD-DP092:001
UPCMLD-DP092:002
Vinas brand OF capsaicin
Vinas Brand of Capsaicin
Zacin
ZINC01530575
Zostrix
ZOSTRIX (TN)
Zostrix HP
|
|
| 3 |
|
Cetirizine |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
83881-51-0 |
2678
|
|
Synonyms:
(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid
(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid
(2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-acetic acid
[(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]acetic acid
2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid
83881-51-0
83881-52-1 (di-hydrochloride)
AC1L1E7T
AC1Q768B
AC-5545
AKOS003589059
Alerlisin
Aliud brand OF cetirizine dihydrochloride
Alpharma brand OF cetirizine dihydrochloride
AWD.pharma brand OF cetirizine dihydrochloride
Azupharma brand OF cetirizine dihydrochloride
Basics brand OF cetirizine dihydrochloride
Benaday
BPBio1_000469
BRD-A42571354-300-05-4
BSPBio_000425
BSPBio_002302
C07778
C21H25ClN2O3
Cetalerg
Ceterifug
Ceti tad
Cetiderm
Cetiderm (TN)
Cetidura
Cetil von CT
CetiLich
Ceti-puren
Cetirigamma
Cetirizin
Cetirizin al
Cetirizin azu
Cetirizin basics
Cetirizina
Cetirizina [Spanish]
cetirizine
Cetirizine (INN)
Cetirizine [INN:BAN]
Cetirizine dihydrochloride
Cetirizine hydrochloride
Cetirizinum
Cetirizinum [Latin]
Cetirlan
Cetrizine Hcl
Cetryn
CHEBI:3561
CHEMBL1000
CID2678
CPD001453715
|
CT-Arzneimittel brand OF cetirizine dihydrochloride
D07662
DB00341
Dermapharm brand OF cetirizine dihydrochloride
Dihydrochloride, cetirizine
glaxo Wellcome brand OF cetirizine dihydrochloride
Hitrizin Film Tablet
HMS1539O07
Humex
I06-0454
Krewel brand OF cetirizine dihydrochloride
L000655
Lacer brand OF cetirizine dihydrochloride
Lichtenstein brand OF cetirizine dihydrochloride
LS-11409
Menarini brand OF cetirizine dihydrochloride
Merck dura brand OF cetirizine dihydrochloride
MLS002222268
MolPort-002-506-309
NCGC00167781-01
NCGC00167781-02
NCGC00167781-03
NCGC00167781-04
nchembio714-comp3
P-071
Pfizer brand OF cetirizine dihydrochloride
Pfizer consumer healthcare brand OF cetirizine dihydrochloride
Prestwick0_000503
Prestwick1_000503
Prestwick2_000503
Prestwick3_000503
Reactine
Rodleben brand OF cetirizine
SAM002589989
Sanofi synthelabo brand OF cetirizine dihydrochloride
Setir
SMR000145214
SPBio_002346
STK711108
STOCK2S-03020
TAD brand OF cetirizine dihydrochloride
TimTec1_002075
UCB brand OF cetirizine dihydrochloride
UCB pharma brand OF cetirizine dihydrochloride
UNII-YO7261ME24
United drug brand OF cetirizine dihydrochloride
Virlix
Voltric
Wolff brand OF cetirizine dihydrochloride
Wörwag brand OF cetirizine dihydrochloride
Zetir
Ziptek
Zirtek
Zyrlex
Zyrtec
|
|
| 4 |
|
Montelukast |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
158966-92-8 |
5281040
|
|
Synonyms:
(R-(e))-1-(((1-(3-(2-(7-chloro-2-Quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetate
(R-(e))-1-(((1-(3-(2-(7-chloro-2-Quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetate
1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulphanyl]methyl]cyclopropaneacetate
1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulphanyl]methyl]cyclopropaneacetic acid
151767-02-1 (sodium)
158966-92-8
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
AC1NQXXW
Apxi toxin
BIDD:GT0394
Brondilat
Brondilat (TN)
C07482
C35H36ClNO3S
Cahill may roberts brand OF montelukast sodium
CHEBI:50730
CHEMBL787
|
CID5281040
D08229
DB00471
HMS2089D07
HSDB 7582
LS-173539
Merck brand OF montelukast sodium
Merck frosst brand OF montelukast sodium
Merck sharp and dohme brand OF montelukast sodium
MK 0476
MK-0476
Montair
montelukast
Montelukast
Montélukast
Montelukast (INN)
Montelukast [INN:BAN]
Montelukast sodium
Montelukastum
Singulair
Singular
sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
Sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
UNII-MHM278SD3E
|
|
| 5 |
|
Nitric Oxide |
Approved |
Phase 4,Not Applicable |
|
10102-43-9 |
145068
160954
|
|
Synonyms:
(.)NO
(no)(.)
(NO)(.)
[no]
[NO]
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous nitrate vasodilator
Endogenous Nitrate Vasodilator
Endothelium-derived nitric oxide
Endothelium-Derived Nitric Oxide
endothelium-derived relaxing factor
Endothelium-derived relaxing factor
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, mononitrogen
Monoxide, Mononitrogen
Monoxide, nitrogen
Monoxide, Nitrogen
monoxido de nitrogeno
monoxido De nitrogeno
Monoxido de nitrogeno
monoxyde d'azote
Monoxyde d'azote
Nitrate vasodilator, endogenous
Nitrate Vasodilator, Endogenous
nitric oxide
|
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, endothelium derived
Nitric Oxide, Endothelium Derived
Nitric oxide, endothelium-derived
Nitric Oxide, Endothelium-Derived
NITRIC-OXIDE
nitrogen monooxide
Nitrogen monooxide
nitrogen monoxide
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
nitrosyl
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
NO
no(.)
NO(.)
OHM 11771
Oxide, nitric
Oxide, Nitric
oxido de nitrogeno(II)
oxido De nitrogeno(II)
Oxido de nitrogeno(ii)
oxido nitrico
oxido Nitrico
Oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(ii)-oxid
Stickstoff(II)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, endogenous nitrate
Vasodilator, Endogenous Nitrate
|
|
| 6 |
|
Azelastine |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
58581-89-8 |
2267
|
|
Synonyms:
37932-96-0 (unspecified hydrochloride)
4-((4-chlorophenyl)methyl)-2- (hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)- phthalazinone HCl
4-((4-Chlorophenyl)methyl)-2- (hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)- phthalazinone HCL
4-((4-Chlorophenyl)methyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone hydrochloride
4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one
4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone
4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone
4-(p-chlorobenzyl)-2-(N-methylperhydroazepinyl-(4))-1-(2H)-phthalazinone
4-(P-Chlorobenzyl)-2-(N-methylperhydroazepinyl-(4))-1-(2H)-phthalazinone
4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one
4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one
58581-89-8
79307-93-0 (hydrochloride)
AC1L1DAR
Afluon
Allergodil
ASTA medica brand OF azelastine hydrochloride
Astelin
Azelastina
Azelastina [INN-Spanish]
azelastine
Azelastine (INN)
Azelastine [INN:BAN]
Azelastine hydrochloride
Azelastinum
Azelastinum [INN-Latin]
Azeptin
Bayer brand OF azelastine hydrochloride
BRD-A68888262-003-02-9
BRN 0900747
BSPBio_003584
|
C07768
C22H24ClN3O
CHEBI:2950
CHEMBL639
CID2267
Corifina
D07483
Dagra brand OF azelastine hydrochloride
DB00972
I06-0157
I14-2736
KBio3_002992
L001153
Loxin
LS-109214
Mann brand OF azelastine hydrochloride
muro Brand OF azelastine
NCGC00177979-01
Optilast
Optivar
Optivar (TN)
Orion brand OF azelastine hydrochloride
Rhinolast
Sanfer brand OF azelastine hydrochloride
SPBio_000657
Spectrum2_000649
Spectrum3_001984
UNII-ZQI909440X
Viatris brand OF azelastine hydrochloride
Vividrin akut azelastin
Wallace brand OF azelastine hydrochloride
|
|
| 7 |
|
Fluticasone |
Approved, Experimental, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
90566-53-3 |
62924
|
|
Synonyms:
90566-53-3
AC1NSJZT
AC-456
BIDD:GT0819
C07815
CHEMBL1201396
CID5311101
D07981
Fluticaps
|
Fluticaps (TN)
Fluticason
Fluticasona
fluticasone
Fluticasone
Fluticasone (INN)
Fluticasonum
MolPort-006-666-449
S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate
|
|
| 8 |
|
Levocetirizine |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
130018-77-8 |
1549000
|
|
Synonyms:
(-)-Cetirizine
(2-(4-((R)-P-chloro-alpha-Phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid
(R)-Cetirizine
2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid
Levocetirizine
|
Levocetirizine dihydrochloride
Levocetrizine
Xazal
Xusal
Xyzal
|
|
| 9 |
|
Ephedrine |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
299-42-3 |
9294
|
|
Synonyms:
( )-Pseudoephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(+)-Ephedrin
(+)-Ephedrine
(+-)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
134910_ALDRICH
1-EPHEDRINE
1-Sedrin
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50906-05-3
50-98-6
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AC-20231
AC-20292
Acunaso
Acunaso (TN)
Afrinol
AI3-02761
AKOS000268842
Ambap299-42-3
AR-1A0126
AR-1I7143
Benylin Decongestant
Besan
BIDD:GT0817
Biophedrin
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
C01575
C02765
C10H15NO
Cenafed
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
D00124
D08449
DB00852
DB01364
Decofed
d-Ephedrine
d-Isoephedrine
DivK1c_000181
DivK1c_000451
DivK1c_000461
d-Pseudoephedrine
d-psi-Ephedrine
Drixoral N.D.
Eciphin
Efedrin
Efidac/24
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
--EPHEDRINE
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine erythro isomer
Ephedrine hydrochloride
Ephedrine l-form
Ephedrine renaudin
Ephedrine sulfate
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
erythro Isomer OF ephedrine
Fedrin
Genaphed
HSDB 3072
HSDB 3177
Hydrochloride, ephedrine
I01-3584
I01-8925
|
I01-8928
IDI1_000181
IDI1_000451
IDI1_000461
I-Sedrin
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
Kratedyn
KST-1A9168
L(−)-ephedrine
L(-)-Ephedrine
L-(-)-Ephedrine
L-(+)-Ephedrine
L(+)-psi-Ephedrine
L000968
l-Ephedrine
L-Ephedrine
L-erythro-2-(methylamino)-1-Phenylpropan-1-ol
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
Lexofedrin
Lopac0_000501
Lopac-E-3250
l-Pseudoephedrine
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Manadrin
Mandrin
Maxenal
MLS000069657
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
Nasol
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI60_002955
NCI-C55652
Neodurasina
Neodurasina (TN)
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
PSEUDOEPHEDRINE
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
racephedrine
Renaudin brand OF ephedrine hydrochloride
Renaudin, ephedrine
Robidrine
Sal phedrine
Sal-phedrine
SalPhedrine
Sanedrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
Spectrum_000878
Spectrum_001020
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
ST023802
STK367993
STOCK1N-42675
Sudafed
Sudafed Decongestant
Sulfate, ephedrine
trans-Ephedrine
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
Wendt brand OF ephedrine sulfate
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
|
|
| 10 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 4,Phase 3 |
|
83-43-2 |
6741
|
|
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
1-dehydro-6alpha-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6a-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6-alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6-Methylprednisolone
6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-wyeth
Artisone-Wyeth
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
delta(1)-6alpha-Methylhydrocortisone
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
Lemod
LMST02030178
LS-118498
M0639_SIGMA
M1665
Medesone
Medixon
Medlone 21
Medrate
Medric acid
|
Medrol
Medrol (TN)
Medrol adt pak
Medrol Adt Pak
Medrol dosepak
Medrol Dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
methylprednisolone
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MLS000028541
MLS001148159
MLS002207191
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
Nirypan
Noretona
NSC19987
NSC-19987
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Reactenol
S1733_Selleck
SAM002589984
Sieropresol
SMR000058330
Solomet
SPBio_002377
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
δ(1)-6a-methylhydrocortisone
δ(1)-6α-methylhydrocortisone
|
|
| 11 |
|
Prednisolone |
Approved, Vet_approved |
Phase 4,Phase 3 |
|
50-24-8 |
5755
|
|
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11b,17a,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Bio-0666
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
Codelcortone
Co-Hydeltra
CO-Hydeltra
component of Ataraxoid
component of K-Predne-Dome
Cordrol
Cortalone
Cotogesic
Cotolone
CPD000718761
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
delta(1)-Cortisol
delta(1)-Dehydrocortisol
Delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
Delta(1)-dehydrohydrocortisone
Delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
Delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Deltacortenol
Deltacortril
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
Delta-Ef-Cortelan
delta-hydrocortisone
Deltahydrocortisone
Deltasolone
Delta-stab
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
Derpo PD
Dexa-Cortidelt hostacortin H
Dexa-Cortidelt Hostacortin H
Di adreson F
Di Adreson F
Di-adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Di-Adreson-F
Dicortol
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
EINECS 200-021-7
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
Hostacortin H
HSDB 3385
Hydeltra
Hydeltrasol
Hydeltra-Tba
Hydeltrone
|
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
Inflamase Forte
Inflamase Mild
I-Pred
K 1557
Key-Pred
Klismacort
Lentosone
Lite Pred
LMST02030179
LS-7669
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
Methylprednisolone Acetate
Meticortelone
Meti-Derm
Metreton
MLS001304083
MLS002154250
MLS002207037
MolPort-002-507-147
M-Predrol
NCGC00179649-01
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
NSC 9120
NSC9120
NSC9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
PRDL
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
prednisolone
Prednisolone (anhydrous)
Prednisolone (JP15/USP/INN)
Prednisolone [INN:BAN:JAN]
Prednisolone acetate
Prednisolone Acetate
Prednisolone sodium phosphate
Prednisolone Sodium Phosphate
Prednisolone tebutate
Prednisolone Tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick_404
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Rolisone
S1737_Selleck
SAM002264639
Scherisolon
SMR000718761
Solone
SPBio_002367
Steran
Sterane
Sterolone
Supercortisol
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-hydrogen
Ultracortene-Hydrogen
UNII-9PHQ9Y1OLM
ZINC03833821
δ(1)-dehydrocortisol
δ(1)-dehydrohydrocortisone
δ(1)-hydrocortisone
|
|
| 12 |
|
Pseudoephedrine |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
90-82-4 |
7028
|
|
Synonyms:
( )-Pseudoephedrine
(+) threo-2-(methylamino)-1-phenyl-1-propanol
(+) threo-2-(methylamino)-1-Phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-Psi-ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(methylamino)-1-Phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC1L1NUA
AC-20292
Acunaso
Acunaso (TN)
Afrinol
alpha-(1-(Methylamino)ethyl)benzyl alcohol
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
C02765
C10H15NO
Cenafed
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
d-Isoephedrine
D-Isoephedrine
DivK1c_000451
d-Pseudoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
d-psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-2-methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
D-Psi-ephedrine
Drixoral N.D.
Drixoral Nasal Decongestant
Efidac 24 Pseudoephedrine Hcl
Efidac/24
EINECS 202-018-6
Eltor 120
Ephedrine
Ephedrine threo isomer
Genaphed
HSDB 3177
|
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L-(+)-Pseudoephedrine
L(+)-psi-Ephedrine
L(+)-Psi-ephedrine
Lopac-E-3250
LS-125922
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
Neodurasina
Neodurasina (TN)
NINDS_000451
Novafed
PDSP1_001347
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
PSEUDOEPHEDRINE
pseudoéphédrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrine D-form
Pseudoephedrine ephedrine
Pseudoephedrine Ephedrine
Pseudoephedrine HCL
Pseudoephedrine hydrochloride
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
Spectrum_000878
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
STOCK1N-42675
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
threo Isomer OF ephedrine
trans-Ephedrine
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
ψ-ephedrine
|
|
| 13 |
|
Xylometazoline |
Approved, Investigational |
Phase 4 |
|
526-36-3 |
5709
|
|
Synonyms:
2-(4'-Tert-butyl-2',6'-dimethylphenylmethyl)imidazoline
Amidrin
Balkis
Balminil
Chlorohist-la
Decongest
Espa-rhin
Gelonasal
Idasal
Idril N
Imidin
Nasan
Nasengel al
NasenGel ratiopharm
Nasenspray al
NasenSpray ratiopharm
|
Nasentropfen al
NasenTropfen ratiopharm
Novorin
Otradrops
Otraspray
Otriven
Otrivin
Otrivin mentol
Rapako
Schnupfen endrine
Snup
Stas
Xylometazoline hydrochloride
Xylometazoline monohydrochloride
Xylomethazoline
|
|
| 14 |
|
Desloratadine |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Not Applicable |
|
100643-71-8 |
124087
|
|
Synonyms:
100643-71-8
8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
8-chloro-11-Piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine
8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine
AC-1279
AC1L3XUD
Aerius
AKOS000280921
Allex
Azomyr
BB_SC-2104
C121345
CHEBI:291342
CHEMBL1172
CID124087
Claramax
Clarinex
Clarinex (TN)
Clarinex Reditabs
Clarinex RediTabs
CPD000149358
D03693
D3787
DB00967
Denosin
Desalex
Descarboethoxyloratadine
Descarboethoxyloratadine acetate
Descarboethoxyoratidine
desloratadine
|
Desloratadine
DESLORATADINE
Desloratadine (USAN/INN)
Desloratadine [USAN]
Desloratidine
Essex brand of desloratadine
HMS2052H05
HMS2090C06
HMS2093F19
I06-1866
L001025
LS-181814
MLS000559042
MLS000759406
MLS001201801
MolPort-000-883-875
NCGC00159325-02
NCGC00159325-03
NCGC00159325-04
Neoclarityn
NeoClarityn
NSC675447
Opulis
SAM001246545
Sch 34117
Sch-34117
Schering brand of desloratadine
Schering-Plough brand of desloratadine
SMR000149358
STK586537
TL8000065
UNII-FVF865388R
|
|
| 15 |
|
Loratadine |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Not Applicable |
|
79794-75-5 |
3957
|
|
Synonyms:
1-Piperidenecarboxylic acid, 4-(8-chloro-5,6-duhydro-11H-benzo [5,6]cyclohepta[1,2-b]-pyridin-11-ylidene)-, ethyl ester
1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, ethyl ester
1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-, ethyl ester
1-piperidinecarboxylic acid,4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-,ethyl ester
4-(8-chloro-5,6-dihydro-11H-benzo(5,6)Cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester
4-(8-Chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic Acid Ethyl Ester
4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acid ethyl ester
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acid ethyl ester
79794-75-5
AC1L1H3E
AC-2086
Aerotina
Alarin
Alavert
Alavert, Claritin, Loratadine
Alerpriv
Allertidin
Amantadine
Anhissen
BB_SC-2109
Bedix Loratadina
BIDD:GT0198
Biloina
Bonalerg
BRD-K82795137-001-02-3
BRD-K82795137-001-10-6
BSPBio_002300
C22H23ClN2O2
CHEMBL998
Children's Claritin
CID3957
Civeran
Claratyne
Claratyne Cold
Claratyne Decongestant
Clarinase
Clarinase Reperabs
Claritin
Claritin (TN)
Claritin D
Claritin Hives Relief
Claritin Hives Relief Reditab
Claritin reditab
Claritin Reditabs
Claritine
Clarityn
Clarityne
Clarityne Dy Repetabs
Clarityne-D
Clarium
CPD000058255
Cronopen
D00364
D017336
DB00455
DivK1c_000792
Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylate
ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
EU-0100680
Flonidan
Fristamin
Histaloran
HMS2051G11
HMS2090O18
HMS2093I15
HMS502H14
HSDB 3578
I14-0747
IDI1_000792
KBio1_000792
KBio2_001976
KBio2_004544
KBio2_007112
KBio3_001520
KBioGR_000693
KBioSS_001976
Klaritin
L 9664
L000667
L0223
L9664_SIGMA
Lergy
|
Lertamine
Lesidas
Lisino
Lopac0_000680
Lopac-L-9664
Loracert
Loradex
Loradif
Loranox
Lorantis
Lorastine
Loratadina
Loratadina [Spanish]
loratadine
Loratadine (JAN/USAN/INN)
Loratadine [USAN:BAN:INN]
Loratadine Redidose
Loratadine wyeth brand
Loratadine Wyeth Brand
Loratadinum
Loratadinum [Latin]
Loratidine
Loratyne
Loraver
Lorfast
Loritine
Lowadina
LS-114660
MLS000069647
MLS000758260
MLS001148466
MolPort-002-507-846
NCGC00015619-01
NCGC00015619-02
NCGC00015619-06
NCGC00015619-10
NCGC00023125-02
NCGC00023125-04
NCGC00023125-05
NCGC00023125-06
NCGC00023125-07
NCI60_041473
NINDS_000792
NSC721075
Nularef
Oprea1_027965
Optimin
Polaratyne
Pylor
Restamine
Rhinase
Rinomex
Roletra
S1358_Selleck
SAM001246987
Sanelor
Sch 29851
Sch29851
Sch-29851
Sensibit
Sinhistan Dy
SMR000058255
Sohotin
SPBio_001548
Spectrum_001496
SPECTRUM1503712
Spectrum2_001584
Spectrum3_000740
Spectrum4_000177
Spectrum5_001650
STK574925
Tadine
Talorat Dy
TL8005389
Tocris-1944
UNII-7AJO3BO7QN
Velodan
Versal
Wyeth brand OF loratadine
Wyeth Brand of Loratadine
Zeos
ZINC00537931
|
|
| 16 |
|
Oxymetazoline |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
1491-59-4 |
4636
|
|
Synonyms:
1491-59-4
2-(4-tert-Butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol
3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol
AC1L1IM1
AC-6370
Afrin Cherry 12 Hour Nasal Spray
Afrin Extra Moisturizing 12 Hour Nasal Spray
Afrin Original 12 Hour Nasal Spray
Afrin Original 12 Hour Nose Drops
Afrin Original 12 Hour Pump Mist
Afrin Sinus 12 Hour Nasal Spray
Biomol-NT_000161
BPBio1_000295
BPBio1_000419
BRD-K16195444-001-01-7
BRN 0886303
BSPBio_000267
BSPBio_002145
C07363
CAS-151615
CHEBI:142520
CHEMBL762
CID4636
D010109
D08322
DB00935
DivK1c_000567
Dristan Long Lasting Mentholated Nasal Spray
Dristan Long Lasting Nasal Mist
Drixoral Nasal Solution
Duramist Plus Up To 12 Hour Nasal Decongestant Spray
EINECS 216-079-1
FT-0082560
Genasal Nasal Spray Up to 12 Hour Relief
H 990
Hazol
HMS2089G03
HSDB 3143
Hydrochloride, oxymetazoline
IDI1_000567
Iliadin
KBio1_000567
KBio2_001531
KBio2_004099
KBio2_006667
KBio3_001645
KBioGR_000908
KBioSS_001531
L000459
Lopac0_000903
Lopac-O-2378
|
LS-104146
MolPort-002-538-313
Nafrine
Nasal Relief 12 Hour Nasal Spray
Navasin
Navisin
NCGC00015766-01
NCGC00015766-02
NCGC00015766-03
NCGC00015766-10
NCGC00022345-02
NCGC00022345-04
NCGC00022345-05
NCGC00022345-06
nchembio705-11
Neo-Synephrine 12 Hour Spray
Nezeril
NINDS_000567
Nostrilla 12 Hour Nasal Decongestant
Operil (TN)
Oximetazolina
Oximetazolina [INN-Spanish]
Oximetazolinum
Oxylazine
oxymeta zoline
Oxymetazolina
oxymetazoline
Oxymetazoline (INN)
Oxymetazoline [INN:BAN]
Oxymetazoline hydrochloride
oxymetazoline hydrochloride crystalline
Oxymetazoline hydrochloride crystalline
Oxymetazolinum
Oxymetazolinum [INN-Latin]
Oxymethazoline
Oxymetozoline
Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl- (9CI)
Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl- (7CI,8CI)
Prestwick0_000224
Prestwick1_000224
Prestwick2_000224
Prestwick3_000224
Rhinofrenol
Rhinolitan
Sinerol
SPBio_001095
SPBio_002188
Spectrum_001051
Spectrum2_000998
Spectrum3_000533
Spectrum4_000464
Spectrum5_001114
Tocris-1142
UNII-8VLN5B44ZY
Vicks Sinex 12 Hour Nasal Spray
Vicks Sinex 12 Hour Ultra Fine Mist for Sinus Relief
Visine L.R
Visine L.R.
|
|
| 17 |
|
Phenylephrine |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
59-42-7 |
6041
|
|
Synonyms:
(-)-m-Hydroxy-a-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-α-(methylaminomethyl)benzyl alcohol
(R)-2-Hydroxy-2-(3-hydroxyphenyl)-N-methylethylamine
(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol
1416-03-1
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol
59-42-7
61-76-7 (hydrochloride)
AC1L1LO9
AC1Q40UF
Adrianol
Ah-Chew
AI3-02402
Ak-dilate
AK-Dilate
Ak-nefrin
AK-Nefrin
Alcon efrin
Alcon Efrin
Alconefrin nasal drops 12
Alconefrin Nasal Drops 12
Alconefrin nasal drops 25
Alconefrin Nasal Drops 25
Alconefrin nasal drops 50
Alconefrin Nasal Drops 50
Alconefrin nasal spray 25
Alconefrin Nasal Spray 25
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)- (9CI)
BIDD:GT0157
Biomydrin
BSPBio_002420
C07441
CCRIS 8464
CHEBI:8093
CHEMBL1215
CID6041
Cyclomydril
D08365
DB00388
Dilatair
Dimetane
Dionephrine
DivK1c_000597
Doktors
Duration
EINECS 200-424-8
EINECS 215-810-1
Fenilefrina
Fenilefrina [INN-Spanish]
HSDB 3383
IDI1_000597
I-phrine
I-Phrine
Isophrim
Isophrin
isopto Frin
Isopto Frin
KBio1_000597
KBio2_001581
KBio2_004149
KBio2_006717
KBio3_001640
KBioGR_001313
KBioSS_001581
l-(3-Hydroxyphenyl)-N-methylethanolamine
L-(3-Hydroxyphenyl)-N-methylethanolamine
l-1-(m-Hydroxyphenyl)-2-methylaminoethanol
l-alpha-Hydroxy-beta-methylamino-3-hydroxy-L-ethylbenzene
l-m-Hydroxy-alpha-((methylamino)methyl)benzyl alcohol
Lopac0_000920
Lopac-P-6126
L-Phenylephedrine
L-Phenylephrine
LS-43027
Mesaton
Mesatone
Mesatonum
Metaoxedrin
Metaoxedrine
Metaoxedrinum
Metasympatol
|
Metasynephrine
Metsatonum
Mezaton
Minims phenylephrine
Minims Phenylephrine
m-Methylaminoethanolphenol
M-Methylaminoethanolphenol
MolPort-001-792-191
m-Oxedrine
M-Oxedrine
m-Sympathol
M-Sympathol
m-Sympatol
M-Sympatol
m-Synephrine
M-Synephrine
Mydfrin
NCGC00015825-01
NCGC00015825-02
NCGC00024257-03
NCGC00024257-05
NCGC00024257-06
neo Synephrine
Neofrin
Neophryn
neo-Synephrine
Neosynephrine
Neo-Synephrine
neo-Synephrine nasal drops
Neo-Synephrine Nasal Drops
neo-Synephrine nasal jelly
Neo-Synephrine Nasal Jelly
neo-Synephrine nasal spray
Neo-Synephrine Nasal Spray
neo-Synephrine pediatric nasal drops
NINDS_000597
Nostril
Nostril spray pump
Nostril Spray Pump
Nostril spray pump mild
Nostril Spray Pump Mild
Ocugestrin
Ocu-phrin sterile eye drops
Ocu-Phrin Sterile Eye Drops
Ocu-phrin sterile ophthalmic solution
P0395
PDSP1_001108
PDSP2_001092
Phenoptic
phenylephrine
Phenylephrine
Phenylephrine (INN)
Phenylephrine [INN:BAN]
Phenylephrine hydrochloride
Phenylephrine Minims
Phenylephrine Minims (TN)
Phenylephrine tannate
Phenylephrinum
Phenylephrinum [INN-Latin]
Prefrin
Prefrin liquifilm
Prefrin Liquifilm
Pyracort D
R(-)-Mezaton
R(-)-Phenylephrine
Relief eye drops for red eyes
Relief Eye Drops for Red Eyes
Rhinall
SPBio_001280
Spectrum_001101
Spectrum2_001280
Spectrum3_000770
Spectrum4_000967
Spectrum5_001411
Spersaphrine
Tannate, phenylephrine
Tannins, compds. with (R)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol
UNII-1WS297W6MV
Vicks sinex
Vicks Sinex
Visadron
|
|
| 18 |
|
Betamethasone |
Approved, Vet_approved |
Phase 4,Phase 3 |
|
378-44-9 |
9782
|
|
Synonyms:
.beta.-Methasone
.beta.-Methasone alcohol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16b-Methyl-1,4-pregnadiene-9a-fluoro-11b,17a,21-triol-3,20-dione
16β-methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
24024-03-1
34166_FLUKA
34166_RIEDEL
378-44-9
4-08-00-03501 (Beilstein Handbook Reference)
9.alpha.-Fluoro-16.beta.-methylprednisolone
9a-fluoro-16b-Methylprednisolone
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-fluoro-16beta-Methylprednisolone
9alpha-Fluoro-16beta-methylprednisolone
9-alpha-Fluoro-16-beta-methylprednisolone
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-fluoro-16beta-Methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-fluoro-16b-Methylprednisolone
9-fluoro-16β-methylprednisolone
9-Fluoro-16β-methylprednisolone
9α-fluoro-16β-methylprednisolone
9α-Fluoro-16β-methylprednisolone
AC1L1EYE
AC1L1TT4
AC1Q5HJZ
AKOS001582690
AR-1A7284
AR-1H5595
B1837
B7005_SIAL
B7005_SIGMA
B9675_SIAL
Bebate
Becort
Bedifos
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
betamethasone
beta-Methasone
Betamethasone
Betamethasone (JP15/USP/INN)
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
beta-Methasone alcohol
Betamethasone alcohol
Betamethasone Base
Betamethasone cream
Betamethasone Valearate
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
Betasolon
Betnelan
Betsolan
|
BIDD:PXR0047
b-Methasone alcohol
BPBio1_000533
BRD-A35108200-001-04-7
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
C22H29FO5
Celestene
Celeston
Celestona
Celestone
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
CHEBI:3077
CHEMBL632
CID3003
CID9782
Cidoten
CPD000339803
D00244
D1961
DB00443
Desacort-Beta
EINECS 206-825-4
Flubenisolone
HMS1569I05
Hormezon
HSDB 3015
I06-0121
KST-1A3042
LS-118466
LT00441022
Luxiq
Luxiqo
Methazon
MLS000686794
MLS000859943
MLS001066413
MLS001332616
MLS002153244
MLS-0310139.0001
MolPort-003-845-025
MolPort-007-981-051
NCGC00164401-01
NCGC00164401-02
NSC 39470
NSC39470
NSC-39470
Prestwick_703
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Rinderon
Rinderon (TN)
Rinderon A
S1500_Selleck
SAM002589959
SCH 4831
SCH-4831
SMP1_000043
SMR000058601
SMR000339803
SPBio_002404
UNII-9842X06Q6M
Valisone
Visubeta
ZINC03876136
β-methasone alcohol
|
|
| 19 |
|
Omalizumab |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
242138-07-4 |
|
|
Synonyms:
242138-07-4
D05251
Omalizumab
Omalizumab (genetical recombination)
|
Omalizumab (genetical recombination) (JAN)
Omalizumab (USAN/INN)
Xolair
Xolair (TN)
|
|
| 20 |
|
Ciclesonide |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1 |
|
126544-47-6, 141845-82-1 |
444033
|
|
Synonyms:
(R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate
126544-47-6
141845-82-1
AC-1330
Alvesco
Alvesco (TN)
Alvesco HFA
B-9207-015
BTR-15
BTR-15K
BY-9010
BYK-20426
Ciclesonide
Ciclesonide (JAN/USAN/INN)
Ciclesonide [INN]
|
CID6918155
D01703
KS-1165
LS-186047
MolPort-005-940-705
NCGC00167972-01
Omnair
Omnaris
Omnaris HFA
Osonase
Osonide
RPR 251526
TBN-15
UNII-S59502J185
|
|
| 21 |
|
Budesonide |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
51333-22-3 |
63006
5281004
|
|
Synonyms:
(11b,16a)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11β,16α)-16,17-(butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
AC-4697
B 7777
B7777_SIGMA
Bidien
Bio-0010
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Budecort Inhaler
Budenofalk
Budeson
budesonide
Budesonide (JAN/USAN/INN)
Budesonide [USAN:INN:BAN:JAN]
Budesonide Easyhaler
Budesonide MMX
Budesonide, (R)-isomer
Budesonide, (S)-isomer
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
Cortivent
CPD000058337
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
Entocort
Entocort EC
Entocort EC (TN)
EU-0100174
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
|
HMS501H17
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
Lopac0_000174
LS-187734
LS-7235
MAP-0010
Micronyl
Miflonide
MLS000028507
MLS001077323
MLS002207112
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick_840
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort turbuhaler
Pulmicort Turbuhaler
Respules
Rhinocort
Rhinocort alpha
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S1286_Selleck
S-1320
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
ST51039033
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
|
|
| 22 |
|
Fexofenadine |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1 |
|
83799-24-0 |
3348
|
|
Synonyms:
159389-12-5
2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid
2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid
4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-a,a-dimethylbenzeneacetate
4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-a,a-dimethylbenzeneacetic acid
4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetate
4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid
4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-α,α-dimethylbenzeneacetate
4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-α,α-dimethylbenzeneacetic acid
76815-58-2
83799-24-0
AC1L1FQB
Allegra
Allegra-D 12 Hour
Allegra-D 24 Hour
alpha-(4-(1-Carboxy-1-methylethyl)phenyl)-4-hydroxydiphenylmethyl-1-piperidinebutanol
Aventis behring brand OF fexofenadine hydrochloride
Aventis brand OF fexofenadine hydrochloride
Aventis pharma brand OF fexofenadine hydrochloride
BRD-A73368467-003-02-8
BSPBio_003521
C06999
C32H39NO4
Carboxyterfenadine
CHEBI:5050
CHEMBL914
CID3348
D07958
DB00950
EU-0100488
F 9427
fexofenadine
Fexofenadine
Fexofenadine (INN)
Fexofenadine [INN:BAN]
Fexofenadine hydrochloride
|
Fexofendine
Hoechst brand OF fexofenadine hydrochloride
HSDB 7486
KBio2_002449
KBio2_005017
KBio2_007585
KBio3_002742
KBioGR_000807
KBioSS_002456
L000869
Lopac0_000488
LS-28827
MDL 16,455a
MDL 16455
MolPort-002-508-207
NCGC00015453-03
NCGC00015453-06
NCGC00092389-02
NCGC00092389-03
SPBio_001197
Spectrum_001914
Spectrum2_001179
Spectrum3_001921
Spectrum4_000204
Spectrum5_001474
STK624102
STOCK6S-26154
Telfast
Telfast (TN)
Terfenadine acid metabolite
Terfenadine carboxylate
Terfenadine carboxylic acid
Terfenadine-COOH
Terfenidine carboxylate, MDL 16455
UNII-E6582LOH6V
|
|
| 23 |
|
Adenosine |
Approved, Investigational |
Phase 4,Phase 2,Phase 1 |
|
58-61-7 |
60961
|
|
Synonyms:
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
1-(6-amino-9H-Purin-9-yl)-1-deoxy-beta-delta-ribofuranose
1-(6-amino-9H-Purin-9-yl)-1-deoxy-beta-D-ribofuranose
1odi
2fqy
2gl0
30143-02-3
46946-45-6
46969-16-8
4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside
58-61-7
6-Amino-9-.beta.-ribofuranosyl-9H-purine
6-amino-9-b-D-Ribofuranosyl-9H-purine
6-amino-9beta-delta-Ribofuranosyl-9H-purine
6-amino-9beta-D-Ribofuranosyl-9H-purine
6-amino-9-beta-D-Ribofuranosyl-9H-purine
6-Amino-9beta-D-ribofuranosyl-9H-purine
6-Amino-9-beta-D-ribofuranosyl-9H-purine
6-amino-9-β-D-ribofuranosyl-9H-purine
9-(beta-D-Arabinofuranosyl)adenine
9-b-D-Ribofuranosidoadenine
9-b-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Arabinofuranosyladenine
9-beta-delta-Arabinofuranosyladenine
9-beta-delta-Ribofuranosidoadenine
9beta-delta-Ribofuranosyl-9H-purin-6-amine
9-beta-delta-Ribofuranosyl-9H-purin-6-amine
9beta-delta-Ribofuranosyladenine
9-beta-delta-Ribofuranosyladenine
9-beta-D-Ribofuranosidoadenine
9beta-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Ribofuranosyl-9H-purin-6-amine
9beta-D-Ribofuranosyladenine
9-beta-D-Ribofuranosyladenine
9-β-D-ribofuranosidoadenine
9-β-D-ribofuranosyl-9H-purin-6-amine
A0152
A4036_SIGMA
A9251_SIGMA
AC1L1U8O
AC1Q1ID3
AC1Q52XU
Adenin riboside
Adenine 9-beta-D-arabinofuranoside
Adenine deoxyribonucleoside
Adenine Deoxyribonucleoside
Adenine nucleoside
Adenine riboside
Adenine-9beta-delta-ribofuranoside
Adenine-9beta-D-ribofuranoside
Adenine-9-beta-D-ribofuranoside
adenine-D-ribose
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenogesic
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosina
adenosine
Adénosine
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine, homopolymer
Adenosinum
Adensoine
Adenyldeoxyriboside
Ade-rib
Ade-Rib
|
ADN
Ado
AI3-52413
BB_NC-0565
b-D-Adenosine
beta-Adenosine
beta-D-Adenosine
beta-delta-Adenosine
beta-D-Ribofuranoside, adenine-9
Bio1_000437
Bio1_000926
Bio1_001415
bmse000061
Boniton
BSPBio_001796
C00212
Caswell No. 010B
CCRIS 2557
CHEBI:16335
CHEMBL477
CID60961
D000241
D00045
DB00640
Deoxyadenosine
Desoxyadenosine
EA6C60C2-6AFB-4264-A2F0-541373DB950E
EINECS 200-389-9
FT-0082881
HMS1920A13
HMS2091G13
KBio3_001296
LS-15085
MEDR-640
MLS000069638
MLS002153227
MolPort-001-838-229
Myocol
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
nchembio.143-comp9
nchembio.186-comp109
nchembio.2007.56-comp13
nchembio.64-comp4
nchembio706-5
NSC 627048
NSC 7652
NSC627048
NSC7652
Nucleocardyl
Pallacor
Polyadenosine
Polyriboadenosine
S1647_Selleck
Sandesin
SDCCGMLS-0003108.P003
SMR000058216
SPBio_001194
SPECTRUM1500107
Spectrum2_001257
Spectrum3_000288
SR 96225
SR-96225
SUN-Y4001
TL8003749
UNII-K72T3FS567
USAF CB-10
V0098
Vidarabine
ZINC02169830
β-D-adenosine
|
|
| 24 |
|
Doxazosin |
Approved |
Phase 4 |
|
74191-85-8 |
3157
|
|
Synonyms:
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone
1 (4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine
1-(4-amino-6,7-Dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin
1-(4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[4-(1,4-benzodioxan-2-yl)carpiperazin-1-yl)]-6,7-dimethoxyquinazoline mesylate
2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-bis(methyloxy)quinazolin-4-amine
2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
2-{4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine
74191-85-8
77883-43-3 (mesylate)
AC-11062
AC1L1FAT
AC1Q470P
AC1Q4EXN
AKOS001681453
Alfamedin
Aliud brand OF doxazosin mesylate
Almirall brand OF doxazosin mesylate
Alpharma brand OF doxazosin mesylate
Alter brand OF doxazosin mesylate
apo Doxazosin
apo-Doxazosin
Apogepha brand OF doxazosin mesylate
Apotex brand OF doxazosin mesylate
AstraZeneca brand OF doxazosin mesylate
Azupharma brand OF doxazosin mesylate
Betapharm brand OF doxazosin mesylate
BPBio1_000963
BRD-A13188892-066-03-3
BSPBio_000875
C06970
C23H25N5O5
Cantabria brand OF doxazosin mesylate
Cardular
Cardura
Cardura XL (TN)
Cardura-1
Cardura-2
Cardura-4
Carduran
Carduran neo
CHEBI:4708
CHEMBL707
ChemDiv2_005017
Ciclum brand OF doxazosin mesylate
CID3157
Cinfa brand OF doxazosin mesylate
combino Brand OF doxazosin mesylate
CPD000097306
CT Arzneimittel brand OF doxazosin mesylate
CT-Arzneimittel brand OF doxazosin mesylate
D07874
D9815_SIGMA
DB00590
Diblocin
Doxa puren
Doxacor
Doxagamma
Doxamax
Doxa-puren
Doxatensa
DoxaUro
Doxazomerck
doxazosin
Doxazosin (INN)
Doxazosin [INN:BAN]
Doxazosin al
Doxazosin apogepha
Doxazosin azu
Doxazosin beta
Doxazosin findusfit
Doxazosin heumann
Doxazosin klast
Doxazosin mesilate
Doxazosin mesylate
Doxazosin monohydrochloride
Doxazosin ratiopharm
|
Doxazosin stada
Doxazosin von CT
Doxazosin wolff
Doxazosina
Doxazosina [Spanish]
Doxazosina alter
Doxazosina cinfa
Doxazosina combino pharm
Doxazosina geminis
Doxazosina normon
Doxazosina pharmagenus
Doxazosina ratiopharm
Doxazosina ur
Doxazosine
Doxazosine [French]
Doxazosin-ratiopharm
Doxazosinum
Doxazosinum [Latin]
Doxazosin-wolff
Esparma brand OF doxazosin mesylate
FindusFit brand OF doxazosin mesylate
Geminis brand OF doxazosin mesylate
Gen doxazosin
Gen-doxazosin
Genpharm brand OF doxazosin mesylate
Heumann brand OF doxazosin mesylate
Hexal brand OF doxazosin mesylate
HMS1383E01
HMS2090C20
I06-1346
IDI1_003732
Juta brand OF doxazosin mesylate
Jutalar
Kade brand OF doxazosin mesylate
L000738
Linden brand OF doxazosin mesylate
Lopac0_000474
LS-110228
Merck dura brand OF doxazosin mesylate
Mesylate, doxazosin
MolPort-001-684-491
Monohydrochloride, doxazosin
MTW Brand OF doxazosin mesylate
MTW Doxazosin
MTW-Doxazosin
NCGC00018158-06
NCGC00089775-02
neo, Carduran
Normon brand OF doxazosin mesylate
Normothen
novo Doxazosin
novo-Doxazosin
Novopharm brand OF doxazosin mesylate
Oprea1_259518
Pfizer brand OF doxazosin mesylate
Pharmagenus brand OF doxazosin mesylate
Prestwick0_000858
Prestwick1_000858
Prestwick2_000858
Prestwick3_000858
Progandol neo
Q Pharm brand OF doxazosin mesylate
Q-Pharm brand OF doxazosin mesylate
ratio Doxazosin
ratio-Doxazosin
Ratiopharm brand OF doxazosin mesylate
Ratiopharm, doxazosina
SAM002589981
Solvay brand OF doxazosin mesylate
SPBio_002796
Stadapharm brand OF doxazosin
TAD brand OF doxazosin mesylate
UK 33274
UK-33274
UNII-NW1291F1W8
Uriduct
Wolff brand OF doxazosin mesylate
Wörwag brand OF doxazosin mesylate
Zoxan
|
|
| 25 |
|
Triamcinolone |
Approved, Vet_approved |
Phase 4,Phase 3 |
|
124-94-7 |
31307
|
|
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11b,16a,17a,21-Tetrahydroxy-9a-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9a-fluoro-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9a-fluoro-11b,16a,17a,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9a-fluoro-16a-Hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-fluoro-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-fluoro-11beta,16alpha,17alpha,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-fluoro-16alpha-Hydroxyprednisolone
9alpha-Fluoro-16alpha-hydroxyprednisolone
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC1L1LDH
AC1Q5HJC
AC-2072
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
Bio-0662
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
C21H27FO6
Celeste
CHEMBL1451
CID31307
Cinolone
Cinolone-T
CL 19823
D00385
D014221
DB00620
Delphicort
droxypregna-1,4-diene-3,20-dione
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
ione
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-Ag
Kenacort-AG
Kenalog
Kenalog in Orabase
|
Kenalog-10
Kenalog-40
Kenalog-H
Ledercort
Lopac0_001179
LS-698
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
Nasacort
Nasacort Aq
Nasacort Hfa
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
nchembio.2007.53-comp7
NCI60_000750
NSC 13397
NSC13397
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick_438
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Rodinolone
S1933_Selleck
Sk-Triamcinolone
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
T6376_SIGMA
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Triacet
Triacort
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
triamcinolone
Triamcinolone (JP15/USP/INN)
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triam-Tablinen
Triatex
Tricortale
Triderm
Trilone
Tri-Nasal
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
|
|
| 26 |
|
Epinephrine |
Approved, Vet_approved |
Phase 4,Phase 3,Phase 1 |
|
51-43-4 |
5816
|
|
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-a-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-Adrenalin
(−)-adrenaline
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(−)-adrenaline
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-Adrenaline
(R)-Epinephrine
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51028-73-0
51-43-4
51-43-4 (FREE BASE)
A0173
AC-13188
AC1L1L7B
Acetate, epinephrine
Adnephrine
ADR ADRENALINE
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalina
Adrenalina [DCIT]
adrenaline
Adrenaline
Adrenaline (JP15)
Adrenaline acid tartrate
Adrenaline bitartrate
Adrenaline hydrochloride
Adrenaline/Epinephrine
Adrenalin-Medihaler
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
ADROP
AI3-19015
Allergan brand OF adrenaline hydrochloride
Ana-Guard
Ana-kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthmahaler Mist
Asthmanefrin
Asthma-nefrin
Astmahalin
Astminhal
Balmadren
Bernarenin
BIDD:GT0119
Biorenine
bmse000316
Bosmin
Brevirenin
Bronkaid
Bronkaid mist
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
Chelafrin
CHEMBL679
CID5816
Citanest Forte
Corisol
D00095
d-Adrenaline
DB00668
D-Epifrin
D-Epinephrine
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
epinephrine
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine acetate
Epinephrine bitartrate
Epinephrine hydrochloride
Epinephrine hydrogen tartrate
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
EPIPEN E Z PEN
Epipen EZ Pen
Epipen JR
EPIPEN JR
Epipen Jr.
Epipen Jr. Auto-Injector
|
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
HSCI1_000215
HSDB 4289
Hypernephrin
Hyporenin
Intranefrin
Iontocaine
IOP
Isoptoepinal
Kidoline
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
l-Epinephine
L-epinephrine
L-Epinephrine
l-Epinephrine (synthetic)
l-Epirenamine
L-Epirenamine
Levoadrenaline
levoepinephrine
Levoepinephrine
Levo-Methylaminoethanolcatechol
Levorenen
Levorenin
Levorenine
Levoreninum
l-Methylaminoethanolcatechol
L-Methylaminoethanolcatechol
Lopac-E-4642
LS-156
Lyodrin
Lyophrin
Medihaler-epi
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
nchembio747-comp9
Nephridine
Nieraline
NSC 62786
NSC62786
Paranephrin
PDSP1_001120
PDSP2_001104
Primatene
Primatene mist
Primatene Mist
R-(-)-Epinephrine
Racemic Epinephrine
Racepinephrine
R-Adrenaline
RCRA waste no. P042
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
Scurenaline
Septocaine
Simplene
Sindrenina
SMP1_000227
Soladren
Sphygmogenin
ST069368
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Susphrine
Sus-phrine
Sus-Phrine
SUS-PHRINE SULFITE-FREE
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
|
|
| 27 |
|
Racepinephrine |
Approved |
Phase 4,Phase 3,Phase 1 |
|
329-65-7 |
838
|
|
Synonyms:
(+-)-Adrenaline
(+-)-Epinephrine
2-(methylamino)-1-(3,4-Dihydroxyphenyl)ethanol
Adrenaline hydrochloride, racemic mixture
Adrenaline, racemic
Adrenaline, racemic mixture
Bird brand OF racepinefrine hydrochloride
DL-Adrenaline
Epinephrine hydrochloride, racemic mixture
Epinephrine racemic
Epinephrine, racemic
Epinephrine, racemic mixture
Hydrochloride, racepinephrine
Micronefrin
|
Micronephrine
Mixture adrenaline, racemic
Mixture epinephrine, racemic
Racemic adrenaline
Racemic epinephrine
Racemic mixture adrenaline
Racemic mixture epinephrine
Racepinefrina
Racepinefrine
Racepinefrinum
Racepinephrine
Racepinephrine hydrochloride
Vaponefrin
|
|
| 28 |
|
Diphenhydramine |
Approved, Investigational |
Phase 4,Phase 1 |
|
147-24-0, 58-73-1 |
3100
|
|
Synonyms:
147-24-0
147-24-0 (HYDROCHLORIDE)
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-(Benzhydryloxy)-N,N-dimethylethylamine, hydrochloride
2-(diphenylmethoxy)-N,N-dimethylethanamine
2-(Diphenylmethoxy)-N,N-dimethylethylamine
2-[(diphenylmethyl)oxy]-N,N-dimethylethanamine
2-benzhydryloxyethyl-N,N-dimethylammonium
2-benzhydryloxy-N,N-dimethylethanamine
2-diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
2PM
58-73-1
88637-37-0 (citrate (1:1))
a-(2-Dimethylaminoethoxy)diphenylmethane
AB00053460
AC-13704
AC1L1F65
AKOS003658554
Aleryl
Alledryl
Allerdryl
Allergan
Allergan B
Allergeval
Allergical
Allergina
Allergival
Allermax Caplets
Aller-Med
alpha-(2-Dimethylaminoethoxy)diphenylmethane
Amidryl
Antistominum
Antitussive
Antomin
Automin
Bagodryl
Banophen
Banophen Caplets
Baramine
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
Beldin
Belix
Bena
Benachlor
Benadrin
Benadryl
Benadryl (hydrochloride)
Benadryl Allergy
BENADRYL HCl
Ben-allergin
Benapon
Bendylate
Benhydramin
Benodin
Benodine
Benylan
Benylin
Benzantin
Benzantine
Benzhydramine
Benzhydraminum
Benzhydril
Benzhydroamina
Benzhydryl
beta-Dimethylamino-aethyl-benzhydryl-aether
beta-Dimethylamino-aethyl-benzhydryl-aether [German]
beta-Dimethylaminoethanol diphenylmethyl ether
beta-dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethylbenzhydrylether
Betramin
BIDD:GT0152
BPBio1_000275
BRD-K47278471-003-05-7
BRN 1914136
BSPBio_000249
BSPBio_002219
CAS-147-24-0
CCRIS 1959
CHEBI:127629
CHEBI:4636
CHEMBL657
CID3100
Citrate, diphenhydramine
Compoz
CPD-10890
D00300
Dabylen
DB01075
DB06975
Debendrin
Dermistina
Dermodrin
Desentol
Diabenyl
Diabylen
Dibendrin
Dibenil
Dibondrin
Difedryl
Difenhidramina
Difenhidramina [INN-Spanish]
Difenhydramin
Difenhydramine
Difenidramina
Difenidramina [Italian]
Dihidral
Dimedrol
Dimedrol base
Dimedrolum
Dimedryl
|
Dimehydrinate
Dimethylamine benzhydryl ester
Diphamine
Diphantine
Diphen
Diphen Cough
Diphenhist
Diphenhist Captabs
diphenhydramine
Diphenhydramine (JP15/INN)
Diphenhydramine [INN:BAN:JAN]
Diphenhydramine Base
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
Diphenhydramine HCl
Diphenhydramine hydrochloride
DIPHENHYDRAMINE, ANTISTOMINUM, BENZHYDRAMINE
Diphenhydraminum
Diphenhydraminum [INN-Latin]
Diphenylhydramin
Diphenylhydramine
DivK1c_000368
Dobacen
Dormarex 2
Dormin
Dryistan
Drylistan
Dylamon
EINECS 200-396-7
Etanautine
FAR 90X2
Genahist
Histaxin
HMS2089E06
HSDB 3066
Hyadrine
Hydramine
Hydrochloride, diphenhydramine
Hyrexin
I14-6749
Ibiodral
IDI1_000368
KBio1_000368
KBio2_001460
KBio2_004028
KBio2_006596
KBio3_001439
KBioGR_001099
KBioSS_001460
L000227
Lopac0_000377
Lopac-D-3630
LS-68208
Medidryl
Mephadryl
MLS002222276
MolPort-001-783-508
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
N-(Benzhydryloksy-etylo)dwumetyloamina
N-(Benzhydryloksy-etylo)dwumetyloamina [Polish]
N,N-Dimethyl-2-(diphenylmethoxy)-ethylamine hydrochloride
N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE
Nausen
NCGC00015335-01
NCGC00015335-02
NCGC00015335-03
NCGC00015335-10
NCGC00024414-03
NCGC00024414-04
nchembio747-comp18
NCI60_002916
NCI60_022782
Nervine Nighttime Sleep-Aid
NINDS_000368
Novamina
NSC665800
Nytol Quickcaps
Nytol Quickgels
O-benzhydryldimethylaminoethanol
O-Benzhydryldimethylaminoethanol
Oprea1_254625
PM 255
Prestwick0_000065
Prestwick1_000065
Prestwick2_000065
Prestwick3_000065
Probedryl
Restamin
Restamin (TN)
Rigidil
S51
Siladryl
Silphen
Sleep-Eze D
Sleep-Eze D Extra Strength
SMR001307259
SPBio_000961
SPBio_002170
Spectrum_000980
Spectrum2_000961
Spectrum3_000400
Spectrum4_000520
Spectrum5_000915
STK103720
STOCK2S-94461
Syntedril
Syntodril
TL8003758
Twilite Caplets
UNII-8GTS82S83M
Unisom Sleepgels Maximum Strength
α-(2-dimethylaminoethoxy)diphenylmethane
β-dimethylaminoethanol diphenylmethyl ether
β-dimethylaminoethyl benzhydryl ether
|
|
| 29 |
|
Promethazine |
Approved, Investigational |
Phase 4,Phase 1 |
|
60-87-7 |
4927
|
|
Synonyms:
(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(2-dimethylamino-2-Methyl)ethyl-N-dibenzoparathiazine
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(Dimethylamino-2-propyl-10-phenothiazine hydrochloride
10-(2-(Dimethylamino)-2-methylethyl)phenothiazine
10-(2-(Dimethylamino)propyl)phenothiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(dimethylamino)Propyl]phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl- (9CI)
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, radical ion(1+)
3277 RP
3389 R.p.
38878-40-9
4182 R.p.
4-27-00-01253 (Beilstein Handbook Reference)
60-87-7
73745-50-3
A-91033
AB00053535
AC-15939
AC1L1J92
Antiallersin
Aprobit
Atosil
Avomine
BPBio1_000744
BRN 0088554
BSPBio_000676
BSPBio_002777
C07404
Camergan
CCRIS 7056
CHEBI:8461
CHEMBL643
CID4927
D00494
DB01069
Dimapp
Dimethylamino-isopropyl-phenthiazin
Dimethylamino-isopropyl-phenthiazin [German]
Diphergan
Diprazin
Diprazine
Diprozin
DivK1c_000005
EINECS 200-489-2
Fargan
Fenazil
Fenetazina
Fenetazine
Genphen
Hiberna
Histargan
HMS2089E08
HSDB 3173
Hydrochloride, promethazine
IDI1_000005
Iergigan
InChI=1/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3
Isophenergan
Isopromethazine
KBio1_000005
KBio2_001348
KBio2_003916
KBio2_006484
KBio3_001997
KBioGR_001697
KBioSS_001348
L000495
Lercigan
Lergigan
Lilly 01516
Lilly 1516
Lopac0_000899
LS-264
Metaryl
MolPort-001-783-684
N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,α-trimethyl-10H-phenothiazine-10-ethanamine
N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine
|
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine hydrochloride
NCGC00015817-10
NCGC00089735-02
NCGC00089735-03
NCI60_001878
NCI-C60673
N-Dimethylamino-2-methylethyl thiodiphenylamine
NINDS_000005
NSC 30321
NSC30321
Oprea1_758749
Pelpica
Phargan
Phenargan
Phenergan
Phenerzine
Phenoject-50
Phensedyl
Pilothia
Pilpophen
Pipolfen
Pipolphen
Pipolphene
Prestwick0_000888
Prestwick1_000888
Prestwick2_000888
Prestwick3_000888
Pro-50
Proazaimine
Proazamine
Procit
Promacot
Promazinamide
Promergan
Promesan
Promet
Prometasin
Prometazin
Prometazina
Prometazina [INN-Spanish]
Prometazine
Prometh
Promethacon
Promethaine
Promethazin
promethazine
Promethazine
Promethazine (JAN/INN)
PROMETHAZINE (SEE ALSO PROMETHAZINE HYDROCHLORIDE 58-33-3)
Promethazine [INN:BAN]
Promethazine hydrochloride
PromethazineHcl
Promethazinum
Promethazinum [INN-Latin]
Promethegan
Promethiazine
Promezathine
Prorex
Protazine
Prothazin
Prothazine
Provigan
Pyrethia
Pyrethiazine
Remsed
Romergan
RP 3277
Rumergan
SKF 1498
SPBio_000799
SPBio_002895
Spectrum_000868
Spectrum2_000840
Spectrum3_001019
Spectrum4_001149
Spectrum5_000977
Tanidil
Thiergan
UNII-FF28EJQ494
Valergine
Vallergine
WLN: T C666 BN ISJ B1Y1&N1&1
WY 509
Zipan-25
|
|
| 30 |
|
Tranilast |
Approved, Investigational |
Phase 4 |
|
53902-12-8 |
93543
|
|
Synonyms:
,4&prime
2-((3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid
2-({(2E)-3-[3,4-bis(methyloxy)phenyl]prop-2-enoyl}amino)benzoic acid
2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid
2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino] benzoic acid
3,4-DAA
53902-12-8
AC1NQZP4
AC-940
AKOS002841076
BRD-K17849083-001-02-2
BSPBio_003561
C18H17NO5
CHEMBL415324
CID5282230
CPD000058373
D02027
D27
DB07615
-Dimethoxycinnamoyl)anthranilic Acid
EU-0101193
HMS2051F05
HMS2089L07
HMS2094I21
HSCI1_000076
Lopac0_001193
LS-37150
MK 341
MLS000028468
MLS000759509
MLS001065902
|
MLS001077269
MLS002207030
MolPort-000-375-102
N 5'
N-(3&prime
n-(3',4'-dimethoxycinnamoyl) anthranilic acid
N-(3,4-Dimethoxycinnamoyl)anthranilic acid
NCGC00018185-05
NCGC00018185-09
NCGC00021458-04
NCGC00021458-05
NCGC00021458-07
NU-3450
Rizaben
Rizaben (TN)
Rizaben, SB 252218, MK 341, Tranpro ,Tranilast
S1439_Selleck
SAM001246737
SB-252218
SBB052710
SMR000058373
SPECTRUM1505333
T 0318
T0318_SIGMA
tranilast
Tranilast (JAN/USAN/INN)
Tranilast [USAN:INN:JAN]
tranilastum
Tranilastum
Tranilastum [INN-Latin]
|
|
| 31 |
|
Prazosin |
Approved |
Phase 4 |
|
19216-56-9 |
4893
|
|
Synonyms:
[3H]-Prazosin
[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone
1-(3-Amino-6,7-dimethoxy-2- quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine
1-(4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine
19216-56-9
2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline
2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone
5-25-13-00365 (Beilstein Handbook Reference)
AB00053528
AC1L1J6T
AKOS000310009
BCBcMAP01_000227
Bio1_000365
Bio1_000854
Bio1_001343
Bio2_000358
Bio2_000838
BPBio1_001006
BRD-K49111258-001-02-8
BRD-K49111258-003-05-7
BRN 0768345
BSPBio_000914
BSPBio_001036
BSPBio_002221
C07368
C19H21N5O4
CAS-19237-84-4
CHEBI:8364
CHEMBL2
CID4893
CP-12299
D08411
DB00457
DivK1c_000375
Douglas brand OF prazosin hydrochloride
EINECS 242-885-8
Furazosin
HCL, Prazosin
HMS1362D17
HMS1792D17
HMS1990D17
HMS2089G09
HSDB 3298
Hydrochloride, prazosin
IDI1_000375
IDI1_002113
Justac
KBio1_000375
KBio2_000376
KBio2_001302
KBio2_002944
KBio2_003870
KBio2_005512
KBio2_006438
KBio3_000731
KBio3_000732
KBio3_001721
KBioGR_000376
|
KBioGR_000965
KBioSS_000376
KBioSS_001302
L000666
Lentopres
LS-140002
Minipress
Minipress (TN)
Minipress Xl
MolPort-000-891-036
NCGC00016740-01
NCGC00016740-02
NCGC00016740-03
NCGC00016740-14
NCGC00024324-02
NCGC00024324-04
NCGC00024324-05
NCGC00024324-06
NCGC00024324-07
NCGC00024324-08
NCGC00024324-09
NCI60_002417
NINDS_000375
Oprea1_314778
Pfizer brand OF prazosin hydrochloride
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)- (9CI)
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)- (8CI)
Pratsiol
Prazocin
prazosin
Prazosin (INN)
Prazosin [INN:BAN]
Prazosin HCl
Prazosin HCL
Prazosin hydrochloride
Prazosin Hydrochloride
Prazosina
Prazosina [INN-Spanish]
Prazosine
Prazosine [INN-French]
Prazosinum
Prazosinum [INN-Latin]
Prestwick0_000947
Prestwick1_000947
Prestwick2_000947
Prestwick3_000947
SMP1_000063
SPBio_001297
SPBio_003073
Spectrum_000822
Spectrum2_001289
Spectrum3_000551
Spectrum4_000483
Spectrum5_001365
ST075549
STK301545
TL8001573
TNP00312
Tocris-0623
UNII-XM03YJ541D
Vasoflex
ZINC00601304
|
|
| 32 |
|
Theophylline |
Approved |
Phase 4,Phase 2 |
|
58-55-9 |
2153
|
|
Synonyms:
1,3 Dimethylxanthine
1,3-dimethyl-7H-purine-2,6-dione
1,3-Dimethyl-7H-purine-2,6-dione
1,3-dimethylxanthine
1,3-Dimethylxanthine
111079-49-3
1H-purine-2,6-dione
2a3a
3,7-dihydro-1,3-Dimethyl-1H-purine-2,6-dione
46157-00-0
56645-32-0
58-55-9
75448-53-2
AB00052106
AC1L1D1F
AC-20328
Accurbron
Acet-theocin
Aerobin
Aerolate
Aerolate III
Aerolate SR
Afonilm
Afonilum
Afonilum retard
Afonilum Retard
AI3-50216
AKOS000120961
aminophylline
Aminophylline
Anhydrous, theophylline
Aquaphyllin
Armophylline
Asbron
Asmalix
Asmax
Austyn
BCBcMAP01_000071
BIDD:ER0557
BIDD:GT0151
Bilordyl
BPBio1_000791
BPBio1_001041
Bronchodid Duracap
Bronchoparat
Bronchoretard
Bronkodyl
Bronkodyl SR
Bronkotabs
BSPBio_000719
BSPBio_000945
BSPBio_002363
C07130
C7H8N4O2
CCRIS 4729
Cetraphylline
CHEBI:28177
CHEMBL190
Choledyl sa
Choledyl SA
Chronophyllin
CID2153
Constant T
ConstantT
Constant-T
CPD000058537
CPD-12479
CT Arzneimittel brand OF theophylline sodium glycinate
ct, theo von
CT, theo Von
CT-Arzneimittel brand OF theophylline sodium glycinate
D00371
D013806
DB00277
Diffumal
Dimethylxanthine
Diphyllin
DivK1c_000203
Doraphyllin
Duraphyl
Duraphyllin
Dyspne-inhal
Egifilin
EINECS 200-385-7
Elixex
Elixicon
Elixomin
Elixophyllin
Elixophyllin (TN)
Elixophyllin SR
Elixophyllin(e)
Elixophylline
Etheophyl
Euphylline
Euphylong
Fameasan brand OF theophylline sodium glycinate
Fujisawa brand OF theophylline sodium glycinate
Glycinate, theophylline sodium
Glycine theophyllinate
GS 2591A
HMS1921E03
HMS2089A06
HMS2092M05
HMS500K05
HSDB 3399
Hylate
IDI1_000203
KBio1_000203
KBio2_001518
KBio2_004086
KBio2_006654
KBio3_001583
KBioGR_000785
KBioSS_001518
L000595
Labid
LaBID
Labophylline
Lanophyllin
LASMA
Liquophylline
Liquorice
Lodrane
Lopac0_000014
LS-241
Maphylline
Medaphyllin
MLS000069390
MLS002152943
MLS002153487
MolPort-001-002-058
MolPort-001-737-342
Monospan
Mudrane
Mundipharma brand OF theophylline sodium glycinate
NCGC00018117-01
NCGC00018117-16
NCGC00022112-03
NCGC00022112-04
NCGC00022112-05
NCGC00022112-07
NCGC00022112-08
NCGC00022112-09
NCGC00022112-10
NCGC00022112-11
nchembio.273-comp2
NCI60_001736
NINDS_000203
NSC 2066
NSC2066
Nuelin
Nuelin S.A
Nuelin s.a.
Nuelin S.A.
Nuelin SA
Optiphyllin
Parkophyllin
PDSP1_001018
PDSP1_001234
PDSP2_001002
PDSP2_001218
Physpan
Prestwick0_000820
Prestwick0_000873
Prestwick1_000820
Prestwick1_000873
Prestwick2_000820
Prestwick2_000873
|
Prestwick3_000820
Prestwick3_000873
Pro-vent
Pseudotheophylline
Pulmidur
Pulmo-Timelets
Quibron
Quibron T
Quibron T SR
Quibron t/sr
Quibron T/SR
Quibron TSR
Quibron T-SR
Quibron-T
Quibron-t (TN)
Quibron-t/sr
Quibron-T/SR
Respbid
Respicur
Respid
S1621_Selleck
SAM002554935
slo Phyllin
Slo Phyllin
slo-Bid
Slo-bid
slo-Phyllin
Slo-phyllin
SloPhyllin
SMP1_000291
SMR000058537
Sodium glycinate, theophylline
Solosin
Somophyllin CRT
Somophyllin T
Somophyllin-CRT
Somophyllin-DF
Somophyllin-t
SomophyllinT
Somophyllin-T
SPBio_000823
SPBio_002640
SPBio_002866
Spectrum_001038
SPECTRUM1500568
Spectrum2_000842
Spectrum3_000672
Spectrum4_000353
Spectrum5_001232
Spophyllin retard
ST024762
STK397040
Sustaire
Synophylate
Synophylate-l.a. cenules
T0179
T1633_SIGMA
T4924_SIGMA
T7770_SIGMA
T9031_SIGMA
Talotren
Tefamin
Telbans Dry Syrup
Telb-DS
Teocen 200
Teofilina
Teofilina [Polish]
Teofyllamin
Teolair
Teonova
Teosona
Tesona
Theacitin
Theal tabl.
Theal tablets
theo 24
Theo 24
theo Dur
Theo Dur
theo von ct
theo Von CT
Theo-11
theo-24
Theo24
Theo-24
Theo-24 (TN)
Theobid
Theobid Duracap
THEOBID JR
Theobid jr.
Theobid Jr.
Theochron
Theocin
Theoclair-SR
Theoclear
Theoclear 80
Theoclear l.a.-130
Theoclear L.A.-130
Theoclear la
Theoclear LA
Theoclear-200
Theoclear-80
Theoconfin continuous
Theocontin
Theodel
Theodrip
Theo-DS
theo-Dur
Theodur
Theo-dur
Theodur Dry Syrup
Theodur G
Theodur G (TN)
theo-Dur-sprinkle
Theo-Dur-Sprinkle
Theofol
Theograd
Theokin
Theolair
Theolair (TN)
Theolair-SR
Theolix
Theolixir
Theon
Theona P
Theonite
Theo-Nite
Theo-Organidin
Theopek
Theophyl
Theophyl-225
Theophyline
Theophyllin
Theophyllinate, glycine
theophylline
Theophylline (JP15)
Theophylline anhydrous
Theophylline sodium glycinate
Theophylline, anhydrous
Theophylline-[8-3H
Theophylline-SR
Theophyl-SR
Theoplus
Theo-Sav
Theospan
Theostat
Theostat 80
Theotard
Theovent
T-Phyl
Uni-dur
Uni-Dur
Unifyl
UNII-0I55128JYK
Unilong
Uniphyl
Uniphyl (TN)
Uniphyllin
Uniphyllin continus
Uniphylline
UPCMLD-DP123
UPCMLD-DP123:001
von ct, theo
Von CT, theo
X 115
Xanthium
Xantivent
ZINC18043251
|
|
| 33 |
|
Almotriptan |
Approved, Investigational |
Phase 4 |
|
154323-57-6, 181183-52-8 |
123606
|
|
Synonyms:
1-(((3-(2-(dimethylamino)Ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine
1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine
1-(((3-(2-(dimethylamino)Ethyl)indol-5-yl)methyl)sulphonyl)pyrrolidine
154323-57-6
AC1L3WYP
Almogran
Almotriptan
Almotriptan (USAN)
Almotriptan [USAN:INN:BAN]
Almotriptan malate
Axert
BIDD:GT0048
BRD-K67601717-001-02-0
BSPBio_002731
C17H27N3O2S
CHEBI:520985
CHEMBL1505
CID123606
D02824
DB00918
HMS1922L13
I06-0492
KBio2_002408
|
KBio2_004976
KBio2_007544
KBio3_001951
KBioGR_001647
KBioSS_002414
L000846
LAS-31416
LS-173461
MolPort-003-666-604
N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine
N,N-dimethyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine
NCGC00095135-01
NCGC00095135-02
NCGC00095135-03
PNU-180638
SPBio_000395
Spectrum_001884
SPECTRUM1505204
Spectrum2_000498
Spectrum3_001006
Spectrum4_001134
Spectrum5_001554
UNII-1O4XL5SN61
|
|
| 34 |
|
Resveratrol |
Approved, Experimental, Investigational |
Phase 4,Phase 3 |
|
501-36-0 |
445154
|
|
Synonyms:
(e)-5-(2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
(e)-Resveratrol
(E)-resveratrol
3,4',5-Stilbenetriol
3,4',5-trihydroxystilbene
3,4',5-Trihydroxystilbene
3,4',5-trihydroxy-trans-stilbene
3,4',5-Trihydroxy-trans-stilbene
3,5,4'-trihydroxystilbene
|
3,5,4'-Trihydroxystilbene
5-[(e)-2-(4-Hydroxyphenyl)vinyl]benzene-1,3-diol
5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol
cis-Resveratrol
Resveratrol-3-sulfate
SRT 501
SRT-501
trans-3,4',5 - Trihydroxystilbene
trans-resveratrol
trans-Resveratrol
|
|
| 35 |
|
Pimecrolimus |
Approved, Investigational |
Phase 4 |
|
137071-32-0 |
6447131
17753757
|
|
Synonyms:
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-3-((E)-2-((1R,3R,4S)-4-chloro-3-methoxycyclohexyl)-1-methylvinyl)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,26,26a-hexadecahydro-5,19-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,17,20,21(4H,23H)-tetrone
137071-32-0
33-epi-Chloro-33-desoxyascomycin
33-Epi-chloro-33-desoxyascomycin
ASM 981
ASM-981
ASM-998
CHEMBL1200686
CID6447131
CID6509979
CID6916008
D05480
DB00337
Elidel
Elidel (TN)
|
I06-1252
LS-181798
MolPort-003-666-749
NCGC00167506-01
Novartis brand OF pimecrolimus
Pimecrolimus
Pimecrolimus (JAN/USAN/INN)
Pimecrolimus [USAN:INN:BAN]
Pimecrolimusum
S5004_Selleck
SDZ ASM 981
SDZ-ASM 981
SDZ-ASM-981
UNII-7KYV510875
|
|
| 36 |
|
Tacrolimus |
Approved, Investigational |
Phase 4 |
|
104987-11-3 |
445643
439492
|
|
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
Advagraf
AKOS005145901
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
Anhydrous, tacrolimus
BCBcMAP01_000194
Bio-0921
Bio2_000470
Bio2_000950
BRD-K35452788-001-02-1
BSPBio_001279
BSPBio-001279
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
Cilag brand OF tacrolimus
CPD000466356
CPD-10016
D08556
DB00864
DivK1c_001040
FK 506
FK5
Fk-506
FK506
FK-506
FR 900506
FR900506
|
FR-900506
FT-0082660
Fujimycin
Fujisawa brand OF tacrolimus
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
Janssen brand OF tacrolimus
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
nchembio.2007.23-comp2
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Prograft
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
tacrolimus
Tacrolimus (anhydrous)
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus anhydrous
tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
|
|
| 37 |
|
Ergocalciferol |
Approved, Nutraceutical |
Phase 4,Phase 2,Phase 3 |
|
50-14-6 |
5280793
|
|
Synonyms:
(+)-Vitamin D2
(3b,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-Ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,secoergosta-5,7,10(19)-ol
31316-19-5
47768_SUPELCO
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3ah)-indanylidene]ethylidene]-cyclohexanol
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
beta-Ol
bmse000510
BPBio1_000418
BSPBio_000380
BSPBio_001974
buco-D
Buco-D
C05441
C28H44O
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
Calciferols
Calciferolum
Calciferon 2
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
component of Geltabs Vitamin D
Condacaps
Condocaps
Condol
Crtron
Crystallina
D00187
D2, Vitamin
Daral
D-Arthin
Davitamon D
Davitin
DB00153
Decaps
Dee-osterol
Dee-Osterol
Dee-ron
Dee-Ron
Dee-ronal
Dee-Ronal
Dee-roual
Dee-Roual
delta-Arthin
Deltalin
delta-Tracetten
De-rat concentrate
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
D-Tracetten
E5750_SIGMA
EINECS 200-014-9
Ercalciol
ergocalciferol
|
Ergocalciferol
Ergocalciférol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
'Ergosterol irradiated'
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
Haliver
Hi-deratol
Hi-Deratol
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
Metadee
Mina D2
MLS001332467
MLS001332468
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
Novovitamin-D
NSC 62792
NSC62792
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick_554
Prestwick3_000420
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
Shock-ferol
Shock-ferol sterogyl
SMR000857106
Sorex C.R
Sorex C.R.
SPECTRUM1500276
Spectrum5_000666
ST057150
Sterogyl
STOCK1N-53397
Synthetic vitamin D
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
Vigantol
vio D
vio-D
Vio-D
Viostdrol
Viosterol
Viosterol in oil
Viosterol in Oil
Vitamin D 2
vitamin d-2
Vitamin D2
Vitamin- D2
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
Vitamin-?D2
VITAMIN_D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
|
|
| 38 |
|
Vitamin D |
Approved, Nutraceutical, Vet_approved |
Phase 4,Phase 2,Phase 3 |
|
1406-16-2 |
|
|
Synonyms:
|
|
Vitamin D, unspecified form
|
|
| 39 |
|
Vitamin D3 |
Approved, Nutraceutical |
Phase 4,Phase 2,Phase 3 |
|
67-97-0 |
6221
5280795
|
|
Synonyms:
()-Vitamin D3
(+)-vitamin D3
(+)-Vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(1S,3Z)-3-[(2E)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3Β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
47763_SUPELCO
57651-82-8
67-97-0
7-DEHYDROCHOLESTEROL
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
ACTIVATED
Activated 7-dehydrocholesterol
Arachitol
Bio-0845
bmse000507
BPBio1_000460
BSPBio_000418
BSPBio_002408
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
Calciol
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
cholecalciferol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferols
Cholecalciferolum
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
|
CID7067440
CID7251172
CID7251174
CID9821465
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
colecalciferolum
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Dihydrocholesterol
DivK1c_006276
Duphafral D3 1000
Ebivit
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
FeraCol
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC375571
NSC-375571
Oleovitamin D3
Prestwick_63
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Provitamine
Provitina
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SpecPlus_000180
Spectrum_001163
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
SR-05000001559
SR-05000001559-3
ST057172
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
Vi-de-3-hydrosol
Vigorsan
VITAMIN D
Vitamin D 3
vitamin d-3
Vitamin D3
Vitamin D-3
Vitamin D3 emulsifiable
VITAMIN D3 POWDER
VITAMIN_D3
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
δ-D
|
|
| 40 |
|
Histamine Antagonists |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 41 |
|
Histamine H1 Antagonists |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 42 |
|
Histamine Phosphate |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
51-74-1 |
65513
|
|
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
|
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
LS-78569
UNII-QWB37T4WZZ
|
|
| 43 |
|
Neurotransmitter Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 44 |
|
Antipruritics |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 45 |
|
Dermatologic Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 46 |
|
Peripheral Nervous System Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 47 |
|
Anti-Allergic Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 48 |
|
Anti-Asthmatic Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 49 |
|
Histamine H1 Antagonists, Non-Sedating |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
| 50 |
|
Hormone Antagonists |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 898)
| # |
Name |
Status |
NCT ID |
Phase |
Drugs |
| 1 |
Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis |
Unknown status |
NCT02014623
|
Phase 4 |
Control |
| 2 |
Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites |
Unknown status |
NCT01052610
|
Phase 4 |
sublingual house dust mites allergen extract;placebo in sublingual applicator |
| 3 |
Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis |
Unknown status |
NCT00825656
|
Phase 4 |
Sinol or Sinol-M nasal spray |
| 4 |
Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis |
Unknown status |
NCT00488176
|
Phase 4 |
montelukast;cetirizine;montelukast and cetirizine;placebo |
| 5 |
Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis |
Unknown status |
NCT02402465
|
Phase 4 |
Placebo;Fluticasone propionate;Fluticasone/Azelastine nasal spray |
| 6 |
AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) |
Unknown status |
NCT02238353
|
Phase 4 |
azelastine + fluticasone;Placebo |
| 7 |
Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais |
Unknown status |
NCT01115595
|
Phase 4 |
|
| 8 |
Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy |
Unknown status |
NCT01062139
|
Phase 4 |
Xarlin (Levocetirizine);Cosalin (Petasites hybridus CO2 extract) |
| 9 |
4"S" - Seasonal Symptoms Suppression Study |
Unknown status |
NCT02557269
|
Phase 4 |
Xylometazoline - intranasal application;Azelastine - intranasal application;Mometasone furoate - intranasal application;Hydroxyl-propyl-methyl cellulose powder - intranasal application;Bilastine 20 mg;Prednisolone 5 mg |
| 10 |
Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis |
Unknown status |
NCT02288156
|
Phase 4 |
Capsaicin;placebo |
| 11 |
Anti-inflammatory H1 Antihistamines Allergic Rhinitis |
Completed |
NCT02507635
|
Phase 4 |
Levocetirizine;Desloratadine |
| 12 |
Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis |
Completed |
NCT01550471
|
Phase 4 |
Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo;Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase;QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo;QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris;Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase;Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris |
| 13 |
Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine |
Completed |
NCT02513290
|
Phase 4 |
Bilastine;Loratadine |
| 14 |
Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis |
Completed |
NCT00698594
|
Phase 4 |
|
| 15 |
Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis |
Completed |
NCT02409563
|
Phase 4 |
Budesonide nasal spray (100 mcg bid);Budesonide nasal spray (50 mcg bid |
| 16 |
Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis |
Completed |
NCT02551536
|
Phase 4 |
Montelukast;Fexofenadine;Levocetrizine |
| 17 |
Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms |
Completed |
NCT00460538
|
Phase 4 |
|
| 18 |
Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis |
Completed |
NCT02646904
|
Phase 4 |
Nasal Beclomethasone Dipropionate;CERCHIO 10 mg/ml OS |
| 19 |
Effectiveness Of Therapy With A Thermal Water Nasal Aerosol In Children With Seasonal Allergic Rhinitis |
Completed |
NCT01326247
|
Phase 4 |
|
| 20 |
Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial |
Completed |
NCT00691665
|
Phase 4 |
Olopatadine HCL Nasal Spray, 0.6%;Fluticasone Propionate Nasal Spray, 50 mcg |
| 21 |
Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367) |
Completed |
NCT00442559
|
Phase 4 |
montelukast sodium;inhaled corticosteroid |
| 22 |
Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis |
Completed |
NCT00355771
|
Phase 4 |
Levocetirizine;Placebo |
| 23 |
To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis |
Completed |
NCT00679250
|
Phase 4 |
levocetirizine;placebo to levocetirizine |
| 24 |
POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) |
Completed |
NCT00160537
|
Phase 4 |
Levocetirizine |
| 25 |
Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis |
Completed |
NCT02565212
|
Phase 4 |
Montelukast,mometazon froat |
| 26 |
Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study |
Completed |
NCT02729012
|
Phase 4 |
hypertonic saline solution (NACL 3%+NAHCO3) |
| 27 |
Fluticasone and Salmeterol in Allergic Rhinitis |
Completed |
NCT01388595
|
Phase 4 |
FLUTICASONE PROPRIONATE;Salmeterol;PLACEBO |
| 28 |
Alpha-Blockers in Allergic Rhinitis (MAN 01) |
Completed |
NCT01946035
|
Phase 4 |
Doxazosin XL |
| 29 |
Children, Perennial Allergic Rhinitis (PAR), l-t Growth |
Completed |
NCT00641212
|
Phase 4 |
Budesonide;Placebo |
| 30 |
Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen |
Completed |
NCT01478425
|
Phase 4 |
|
| 31 |
A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis |
Completed |
NCT00653224
|
Phase 4 |
levocetirizine dihydrochloride;placebo |
| 32 |
A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis |
Completed |
NCT00621959
|
Phase 4 |
levocetirizine dihydrochloride;placebo |
| 33 |
Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis |
Completed |
NCT00789555
|
Phase 4 |
Olopatadine hydrochloride 0.6% nasal spray (PATANASE) |
| 34 |
Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis |
Completed |
NCT00894231
|
Phase 4 |
levocetirizine (Xyzal);placebo |
| 35 |
Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Uni |
Completed |
NCT00637611
|
Phase 4 |
Fexofenadine HCl |
| 36 |
Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis |
Completed |
NCT00997620
|
Phase 4 |
Fluticasone furoate Nasal Spray 110 mcg;Placebo |
| 37 |
Allergic Rhinitis Changes the Sinus Microbiome |
Completed |
NCT01852513
|
Phase 4 |
QNASL;Placebo nasal spray |
| 38 |
A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis |
Completed |
NCT00561717
|
Phase 4 |
Azelastine and placebo;Loratadine and Placebo;Cetirizine and Placebo;Placebo and Placebo (spray and Tablet) |
| 39 |
A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis |
Completed |
NCT00609674
|
Phase 4 |
Fluticasone furoate nasal spray;Placebo |
| 40 |
Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR |
Completed |
NCT01880840
|
Phase 4 |
205.5 mcg of azelastine hydrochloride;137 mcg of azelastine hydrochloride |
| 41 |
Study of Bronchodilation Effects of Cetirizine |
Completed |
NCT01781507
|
Phase 4 |
Cetirizine;Placebo |
| 42 |
Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) |
Completed |
NCT00963573
|
Phase 4 |
Loratadine;Betamethasone |
| 43 |
Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431) |
Completed |
NCT00783237
|
Phase 4 |
Mometasone;Placebo |
| 44 |
Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270) |
Completed |
NCT00834119
|
Phase 4 |
Mometasone furoate;Mometasone furoate |
| 45 |
A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) |
Completed |
NCT01654536
|
Phase 4 |
ciclesonide nasal aerosol;ciclesonide nasal spray |
| 46 |
Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) |
Completed |
NCT00449072
|
Phase 4 |
TAA-AQ, Nasacort® AQ;Claritin® |
| 47 |
Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054) |
Completed |
NCT00783146
|
Phase 4 |
desloratadine;fexofenadine;placebo |
| 48 |
Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED) |
Completed |
NCT00783211
|
Phase 4 |
desloratadine;fexofenadine;placebo |
| 49 |
Singulair(R) In Asthma And Allergic Rhinitis (0476-383) |
Completed |
NCT00545844
|
Phase 4 |
montelukast sodium |
| 50 |
Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836) |
Completed |
NCT00867191
|
Phase 4 |
Placebo;Desloratadine |
Inferred drug relations via
UMLS
73
/
NDF-RT
51
:
|
